<!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

Genbank References

BLAST search against GenBank file v. V 185.0 released on 2011-08-15
(search results include 129505 sequences from 1677 references)

This page contains a list of all GenBank entries on HIV-1 protease, RT and integrase grouped by reference. The reference may include a published paper or the title provided with the GenBank submission. The purpose of this page is to show which GenBank entries are in the HIV Drug Resistance Database and which aren't. The last column (Annotation) of the table shows whether or not there are plans to add the entry to the database. Each entry in the Annotation column is linked to a page explaining the annotation.

The entries were created by performing a BLAST search of the GenBank using the consensus B protease, RT and integrase amino acid sequence (give link to the sequences). The E-value column contains the lowest e-value (best match) for all the GenBank entries associated with a specific reference. The columns, # in GB, # in HIVDB, and % in HIVDB indicate the number of entries in GenBank associated with the reference, the number of these entries that are also in the HIV Drug Resistance Database, and the % of GenBank entries from a particular reference that are in the HIV Drug Resistance Database.

For a treatment summary for every isolate in our database and in the GenBank, click here. This file indicates whether or not the person from whom the sequenced virus was obtained had received one or more nucleoside RT inhibitor, nonnucleoside RT inhibitor, or protease inhibitor.


 

AuthorsTitleCitationE-value# in HIVDB# in Gb% in HIVDBAnnotation
Abecasis (2007) RECOMBINATION confounds the early evolutionary history of human immunodeficiency virus type 1: subtype g is a circulating recombinant form J. Virol. 81 (16), 8543-8551 (2007) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Abecasis (2011) Molecular epidemiological analysis of paired pol/env sequences from portuguese HIV-1 patients AIDS Res. Hum. Retroviruses (2011) In press 0  
154
18PR
154RT
0 Pending
Acharya (2009) Human immunodeficiency virus type 1 drug resistance mutations in patients from India Unpublished 1e-178  
1
1RT
0 Unpublished
Achkar (2004) INFECTION with group M non-B HIV-1 subtypes in individuals living in New York City Unpublished 1e-159  
34
34PR
3RT
0 ARV Rx and/or other data are N/A
Adachi (1986) PRODUCTION of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 (2), 284-291 (1986) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Adojaan (2004) PREDOMINANCE of a Rare Type of HIV-1 in Estonia J. Acquir. Immune Defic. Syndr. 39 (5), 598-605 (2005) 0 4
4PR
4RT
4IN
143
142PR
4RT
4IN
2 Gene fragment(s)
Aghokeng (2007) FULL-LENGTH sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages Virology 360 (2), 407-418 (2007) 0 5
3PR
5RT
5IN
5
5RT
5IN
100 HIVDB
Aghokeng (2009) Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries Antivir. Ther. (Lond.) 14 (3), 401-411 (2009) 0 135
135PR
135RT
135
3PR
135RT
100 HIVDB
Aghokeng (2010) Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions Infect. Genet. Evol. (2009) In press 0  
20
2RT
20IN
0 Pending
Aghokeng (2010) Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa J. Gen. Virol. 91 (PT 7), 1810-1816 (2010) 2e-70  
1
1IN
0 Pending
Aghokeng (2011) High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity J. Clin. Microbiol. 49 (4), 1635-1641 (2011) 1e-176  
145
22PR
145RT
0 Pending
Agneskog (2008) CHANGES in mutation patterns of a mosaic genome HIV-1 strain after treatment with nucleoside analogs and the integrase inhibitor raltegravir Unpublished 1e-173  
4
2RT
2IN
0 Pending
Agwale (2003) GENOTYPIC and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive nigerian patients AIDS Res. Hum. Retroviruses 22 (1), 22-26 (2006) 5e-81 18
18PR
18RT
18
18PR
18RT
100 HIVDB
Agwu (2008) Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch Following Initial Nonsuppressive Highly Active Antiretroviral Therapy Unpublished 1e-155  
155
146PR
31RT
0 Pending
Ahuka-Mundeke (2010) Full-length genome sequence a of Simian Immunodeficiency Viruses infecting a captive Agile Mangabey (Cercocebus agilis) is closely related to SIVrcm infecting red-capped mangabeys in Cameroon Unpublished 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Ahumada-Ruiz (2009) Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations Infect. Genet. Evol. 9 (5), 933-940 (2009) 0  
136
80PR
135RT
0 Pending
Ait-Khaled (2002) MUTATIONS in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy Antivir. Ther. (Lond.) 7 (1), 43-51 (2002) 1e-98 156
156RT
156
156RT
100 HIVDB
Albert (1992) PERSISTENCE of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera J. Virol. 66 (9), 5627-5630 (1992) 5e-55 20
20RT
20
20RT
100 HIVDB
Albert (1994) ANALYSIS of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes J. Virol. 68 (9), 5918-5924 (1994) 4e-77 23
23RT
26
26RT
88 HIVDB
Alcalde (2011) Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinants forms which is circulating in Sao Paulo city, Brazil Unpublished 1e-149  
14
12PR
8RT
0 Unpublished
Alexander (2002) INHIBITION of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Two-Amino-Acid Insertion in HIV-1 Vif from a Nonprogressing Mother and Child J. Virol. 76 (20), 10533-10539 (2002) 0.027  
1
1IN
0 Gene fragment(s)
Ali (2010) Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones J. Med. Chem. 53 (21), 7699-7708 (2010) 1e-166  
6
3PR
4RT
0 Laboratory/experimental isolate
Alizon (1986) GENETIC variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients Cell 46 (1), 63-74 (1986) 1e-165 2
1PR
1RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Allan (1993) SPECIES-SPECIFIC diversity among simian immunodeficiency viruses from African green monkeys J. Virol. 65 (6), 2816-2828 (1991) 2e-33  
8
8IN
0 Laboratory/experimental isolate
Allen (2005) SELECTIVE Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol. 79 (21), 13239-13249 (2005) 0  
14
14PR
14RT
14IN
0 Evolution/quasispecies study
Altfeld (2003) HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus Nature 420 (6914), 434-439 (2002) 0  
2
2PR
2RT
0 Case report(s) / study subset
Anderson (2000) TESTING the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E J. Virol. 74 (22), 10752-10765 (2000) 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Anderson (1993) ANALYSIS of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques Virology 195 (2), 616-626 (1993) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Andersson (1999) MOLECULAR characterization of HIV-1 and HIV-2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa Virology 261 (1999) In press 2e-66 7
7RT
7
7RT
100 HIVDB
Andreani (2008) CLINICAL evolution and antiretroviral resistance patterns in HIV-1 dual infected patients in Argentina Unpublished 1e-151  
71
62PR
40RT
0 Pending
Andresen (2007) CHARACTERIZATION of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine AIDS Res. Hum. Retroviruses 23 (11), 1442-1448 (2007) 0 17
17PR
17RT
17IN
17
13PR
17RT
17IN
100 HIVDB
Anta (2010) Identification of a new HIV-1 circulating recombinant form in Spain Unpublished 0  
4
4RT
0 Unpublished
Anton (2004) GENOTYPIC Resistance to Efavirenz/Protease Inhibitor Regimens Unpublished 0  
219
219PR
219RT
0 ARV Rx and/or other data are N/A
Apetrei (1998) HUMAN immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility J. Virol. 72 (5), 3534-3538 (1998) 1e-77 14
14RT
14
14RT
100 HIVDB
Apetrei (2003) HIV type 1 diversity in Northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy AIDS Res. Hum. Retroviruses 19 (12), 1155-1161 (2003) 1e-117 163
77PR
86RT
163
77PR
86RT
100 HIVDB
Apetrei (2004) DIRECT Inoculation of Simian Immunodeficiency Virus from Sooty Mangabeys in Black Mangabeys (Lophocebus aterrimus): First Evidence of AIDS in a Heterologous African Species and Different Pathologic Outcomes of Experimental Infection J. Virol. 78 (21), 11506-11518 (2004) 4e-71  
18
18IN
0 Laboratory/experimental isolate
Apetrei (2005) MOLECULAR Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm J. Virol. 79 (14), 8991-9005 (2005) 4e-90 47
47IN
47
47IN
100 HIVDB
Apetrei (2006) POTENTIAL for HIV transmission through unsafe injections AIDS 20 (7), 1074-1076 (2006) 1e-148  
21
17PR
13RT
0 Pending
Apetrei (2007) SIVSMM Subtypes Induce Specific Immunologic and Virologic Changes in Naturally-Infected Sooty Mangabeys Unpublished 3e-70  
96
96IN
0 Pending
Arien (2005) REPLICATIVE fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time AIDS 19 (15), 1555-1564 (2005) 0 23
23PR
23RT
23
23RT
100 Case report(s) / study subset
Arnold (1995) AT least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England AIDS Res. Hum. Retroviruses 11 (3), 427-429 (1995) 1e-126  
4
4PR
0 Case report(s) / study subset
Arroyo (2004) HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest Tanzania AIDS Res. Hum. Retroviruses 20 (8), 895-901 (2004) 0 20
20PR
20RT
20IN
20
20PR
20RT
20IN
100 HIVDB
Arroyo (2006) HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania AIDS 19 (14), 1517-1524 (2005) 0 14
14PR
14RT
14IN
14
8PR
14RT
14IN
100 HIVDB
Arruda (2009) Genetic diversity on the integrase region of the pol gene among HIV-1-infected patients naive for integrase inhibitors in Sao Paulo city, Brazil AIDS Res. Hum. Retroviruses 26, 1 (2010) 1e-168 76
76IN
76
76IN
100 HIVDB
Arruda (2010) Differences in frequencies of pi-resistance mutations from HIV-1 of different subtypes (B, C and F) in a cohort of patients failing arv therapy Unpublished 0  
869
245PR
787RT
0 Pending
Atkinson (2000) CORRELATION between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine J. Infect. Dis. 182 (2), 420-427 (2000) 1e-123 49
49PR
78
50PR
28RT
62 HIVDB
Aulicino (2004) CIRCULATION of novel HIV type 1 A, B/C, and F subtypes in Argentina AIDS Res. Hum. Retroviruses 21 (2), 158-164 (2005) 0 1
1PR
1RT
1IN
3
2PR
3RT
1IN
33 Case report(s) / study subset
Aulicino (2005) SEQUENCE Analysis of a South American HIV Type 1 BC Recombinant AIDS Res. Hum. Retroviruses 21 (10), 894-896 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Aulicino (2009) HIV-1 non-nucleoside resistance mutations K103N + L100I are strongly associated with nucleoside resistance mutation L74V in BF recombinants from Argentine children under treatment failure, and reduce susceptibility to Etravirine Antivir Ther. 2010;15(4):641-50 3e-52  
8
8PR
0 Pending
Auswinporn (2001) GENOTYPIC subtyping of the HIV-1 polymerase gene in 30 naave patients from Thailand Southeast Asian J. Trop. Med. Public Health 32 (2), 346-350 1e-121 6
6PR
6RT
27
27PR
27RT
22 HIVDB
Auwanit (2001) FULL-LENGTH sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand AIDS Res. Hum. Retroviruses 17 (9), 867-871 (2001) 1e-165  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Auwanit (2009) Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand AIDS Res. Hum. Retroviruses 25 (6), 625-631 (2009) 1e-149 62
43PR
19RT
106
87PR
19RT
58 HIVDB
Avi (2009) Prevalence of Drug Resistance Mutations of Human Immunodeficiency Virus - 1 CRF06_cpx in Treatment-Naive Patients in Estonia in 2008 Unpublished 1e-144 55
55PR
55RT
55
55RT
100 HIVDB
Avi (2009) Polymorphisms of HIV-1 CRF06_cpx integrases in Estonia Unpublished 1e-164 112
112IN
114
114IN
98 HIVDB
AYEHUMIE (1991)   Unpublished (1991) 4e-41  
8
8PR
0 Gene fragment(s)
Ayouba (2009) Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study AIDS Res. Hum. Retroviruses 25 (11), 1193-1196 (20 4e-51 105
105PR
105
105PR
100 HIVDB
Azevedo-Pereira (1998) COMPLETE nucleotide sequence of HIV-2ALI, a low infectious isolate with restricted tropism to primary CD4+ cells Unpublished 2e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Babic (2005) PREVALENCE of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004 Virus Res. 118 (1-2), 156-163 (2006) 0 76
76PR
76RT
76
63PR
76RT
100 HIVDB
Babic (2005) MOLECULAR epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005 J. Med. Virol. 78 (8), 997-1002 (2006) 0  
6
3PR
6RT
0 Case report(s) / study subset
Bacheler (2000) HUMAN immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy Antimicrob. Agents Chemother. 44 (9), 2475-2484 (2000) 1e-130 3669
3646PR
3662RT
3708
3708PR
3708RT
98 HIVDB
Bacheler (2001) GENOTYPIC correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy J. Virol. 75 (11), 4999-5008 (2001) 1e-126 87
84PR
87RT
87
84PR
87RT
100 HIVDB
Badreddine (2007) IDENTIFICATION and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found AIDS Res. Hum. Retroviruses 23 (5), 667-674 (2007) 0 60
6PR
6RT
60IN
60
6RT
60IN
100 HIVDB
Baier (1990) COMPLETE nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence Virology 176 (1), 216-221 (1990) 1e-109 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bailey (2007) EVOLUTION of HIV-1 in an HLA-B*57-Positive Patient during Virologic Escape J. Infect. Dis. 196 (1), 50-55 (2007) 0  
38
35RT
6IN
0 Evolution/quasispecies study
Bailey (2008) TRANSMISSION of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor J. Virol. 82 (15), 7395-7410 (2008) 0  
14
7PR
7RT
14IN
0 Case report(s) / study subset
Balakrishnan (2005) HIV Type 1 Genotypic Variation in an Antiretroviral Treatment-Naive Population in Southern India AIDS Res. Hum. Retroviruses 21 (4), 301-305 (2005) 1e-139 49
49PR
49RT
49
3PR
49RT
100 HIVDB
Baldanti (2010) Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens J. Med. Virol. 82 (1), 116-122 (2010) 1e-156 11
11IN
11
11IN
100 HIVDB
Baldrich-Rubio (2001) A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa J. Gen. Virol. 82 (PT 5), 1095-1106 (2001) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Balode (2010) Direct Submission Submitted (26-JAN-2010) Department of Virology, Sw 7e-50  
1
1PR
0 Unpublished
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 1e-148 107
107PR
107RT
107
79PR
67RT
100 HIVDB
Balode (2010) Direct Submission Submitted (26-JAN-2010) Department of Virology, Sw 1e-143  
6
5PR
4RT
0 Unpublished
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 7e-49 2
2PR
2RT
2
2PR
100 HIVDB
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 2e-48 3
3PR
3RT
3
3PR
100 HIVDB
Balotta (2000) PREVALENCE of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals Antivir. Ther. (Lond.) 5 (1), 7-14 (2000) 1e-128 71
33PR
38RT
71
33PR
38RT
100 HIVDB
Balotta (2000) PREVALENCE of multiple dideoxynucleoside analogue resistance (MddNR) in a multicentric cohort of HIV-1 Italian patients with virologic failure Unpublished 1e-133 149
132PR
149RT
157
137PR
157RT
94 HIVDB
Balotta (2001) INCREASING prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences J. Acquir. Immune Defic. Syndr. 27 (5), 499-505 (2001) 1e-100 19
19PR
19RT
19
19PR
19RT
100 HIVDB
Bang (2007) PREVALENCE of primary antiretroviral resistance: trends in Korea AIDS Res. Hum. Retroviruses 24 (1), 83-85 (2008) 0 81
81PR
81RT
81
77PR
81RT
100 HIVDB
Banke (2009) Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations J. Virol. 83 (17), 8916-8924 (2009) 7e-52  
268
268PR
0 Pending
Bao (2008) MOLECULAR tracing of sexual HIV Type 1 transmission in the southwest border of China AIDS Res. Hum. Retroviruses 24 (5), 733-742 (2008) 0  
2
1PR
2RT
0 Case report(s) / study subset
Bar (2010) Wide variation in the multiplicity of HIV-1 infection among injection drug users J. Virol. 84 (12), 6241-6247 (2010) 3e-16  
390
390IN
0 Evolution/quasispecies study
Bar-Magen (2009) Comparative Biochemical Analysis of HIV-1 Subtype B and C Integrase Enzymes AIDS. 2010 Sep 10;24(14):2171-9. 1e-165  
2
2IN
0 Laboratory/experimental isolate
Barditch-Crovo (2001) PHASE i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults Antimicrob. Agents Chemother. 45 (10), 2733-2739 (2001) 4e-96 14
14RT
14
14RT
100 HIVDB
Barlow (2001) RECOMBINANT strains of HIV type 1 in the United Kingdom AIDS Res. Hum. Retroviruses 17 (5), 467-474 (2001) 1e-109  
12
12PR
9RT
0 ARV Rx and/or other data are N/A
Barlow (2003) CHARACTERIZATION of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona) J. Virol. 77 (12), 6879-6888 (2003) 3e-92 2
1PR
1RT
2IN
2
1RT
2IN
100 HIVDB
Barnett (1993) DISTINGUISHING features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain J. Virol. 67 (2), 1006-1014 (1993) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Barnett (1996) DIRECT Submission Submitted (11-OCT-1995) Barton Bryant, HIV Database, Los Ala 2e-98 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Barreto (2006) TRENDS in Antiretroviral Drug Resistance among HIV-1-Infected Blood Donors in Sao Paulo City, Brazil Unpublished 1e-142 6
6PR
6RT
6
4PR
3RT
100 HIVDB
Barrie (1996) NATURAL variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 Virology 219 (2), 407-416 (1996) 1e-126  
37
37PR
0 Case report(s) / study subset
Bartolo (2007) ANALYSIS of HIV-1 protease and retrotranscriptase in drug-naive patients from Mozambique Unpublished 0 112
36PR
76RT
112
36PR
76RT
100 HIVDB
Bartolo (2007) MOLECULAR epidemiology of HIV-1 in Angola Unpublished 1e-170 140
19PR
121RT
140
19PR
121RT
100 HIVDB
Bartolo (2008) MOLECULAR epidemiology of HIV-1 infection in Maputo, Mozambique, and susceptibility to antiretroviral therapy Unpublished 1e-165 1
1PR
1RT
1
1RT
100 HIVDB
Bartolo (2009) Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic Infect. Genet. Evol. 9 (4), 672-682 (2009) 3e-49 9
9PR
9
9PR
100 HIVDB
Bartolo (2010) Origin and epidemiological history of CRF14_BG Unpublished 0 3
3PR
3RT
3IN
3
3RT
3IN
100 HIVDB
Baxter (2006) GENOTYPIC changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir J. Virol. 80 (21), 10794-10801 (2006) 0 1531
1531PR
1394RT
1534
394PR
1397RT
99 HIVDB
Beck (2007) OPTIMIZATION of the Oligonucleotide Ligation Assay (OLA), a Rapid and Inexpensive Test for Detection of HIV-1 Drug-Resistance Mutations, for Non-B Subtypes Unpublished 8e-53  
16
16PR
0 Case report(s) / study subset
Becker (1995) MOLECULAR and phylogenetic characterisation of a Guinea-Bissau-derived human immunodeficiency virus type 2 isolate Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Becker-Pergola (2000) ANALYSIS of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults AIDS Res. Hum. Retroviruses 16 (8), 807-813 (2000) 1e-115 54
27PR
27RT
54
27PR
27RT
100 HIVDB
Beer (1999) SIMIAN immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies J. Virol. 73 (9), 7734-7744 (1999) 4e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Beer (2000) PATTERNS of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir J. Virol. 74 (8), 3892-3898 (2000) 3e-99 3
3PR
3RT
3IN
3
2PR
3RT
3IN
100 HIVDB
Beer (2001) CHARACTERIZATION of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411) J. Virol. 75 (24), 12014-12027 (2001) 1e-133 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Beerenwinkel (2002) DIVERSITY and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype Proc. Natl. Acad. Sci. U.S.A. 99 (12), 8271-8276 (2002) 1e-126  
489
466PR
467RT
0 Sequence Quality
Bellocchi (2009) Subtype Analysis and Mutations to Antiviral Drugs in HIV-1-Infected Patients From Mozambique Before Initiation of Antiretroviral Therapy: Results From the DREAM Programme J Med Virol (2005) 1e-177 59
59PR
59RT
59
59RT
100 HIVDB
BENVENISTE (1988)   Unpublished (1990) 6e-99 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bermudez-Aza (2011) Antiretroviral resistance in MSM in Brazil Unpublished 1e-153  
142
100PR
90RT
0 Unpublished
Bernardin (2003) PRIMARY Infection of a Male Plasma Donor with Divergent HIV Variants from the Same Source Followed by Rapid Fluctuations in Their Relative Frequency and Viral Recombination AIDS Res. Hum. Retroviruses 19 (11), 1009-1015 (2003) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Bernardin (2004) HUMAN immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes J. Virol. 79 (17), 11523-11528 (2005) 0 18
18PR
18RT
18IN
18
18PR
18RT
18IN
100 HIVDB
Bernardin (2006) DIRECT Submission Submitted (12-DEC-2005) Molecular Virology, Blood Systems Re 0 13
13PR
13RT
13IN
13
13PR
13RT
13IN
100 HIVDB
Bessong (2004) CHARACTERIZATION of Human Immunodeficiency Virus Type 1 from a Previously Unexplored Region of South Africa with a High HIV Prevalence AIDS Res. Hum. Retroviruses 21 (1), 103-109 (2005) 1e-168 26
13PR
13RT
26
13PR
13RT
100 HIVDB
Bessong (2005) RESISTANCE mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals AIDS Res. Hum. Retroviruses 22 (12), 1306-1312 (2006) 1e-177 70
35PR
35RT
70
35PR
35RT
100 HIVDB
Bessong (2010) Analysis of pol integrase gene sequences of HIV-1 infected treatment naive individuals in the Limpopo province of South Africa Unpublished 1e-164  
89
89IN
0 Pending
Bibollet-Ruche (1996) GENETIC diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale J. Virol. 71 (1), 307-313 (1997) 1e-30  
10
10IN
0 Gene fragment(s)
Bibollet-Ruche (2004) NEW simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade J. Virol. 78 (14), 7748-7762 (2004) 0 4
4PR
4RT
4IN
11
4PR
6RT
11IN
36 HIVDB
Bibollet-Ruche (2005) COMPLETE genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2) AIDS Res. Hum. Retroviruses 20 (12), 1377-1381 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Bibollet-Ruche (2005) GENETIC characterization of accessory genes from human immunodeficiency viruses type 1 group O Unpublished 3e-08  
14
14IN
0 Gene fragment(s)
Biesinger (2007) CHANGES in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4(+) T cells Virology 370 (1), 184-193 (2008) 0  
8
8RT
0 Case report(s) / study subset
Binverted question markelec (2000) HIGH levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy J. Infect. Dis. 181 (5), 1808-1812 (2000) 1e-128 100
100PR
100
100PR
100 HIVDB
Blankson (2007) ISOLATION and Characterization of Replication-Competent HIV-1 from a Subset of Elite Suppressors J. Virol. 81 (5), 2508-2518 (2007) 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Blankson (2009) HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject J Infect Dis. 2009 Dec 15;200(12):1820-4. 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Bleiber (2001) INDIVIDUAL contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 J. Virol. 75 (7), 3291-3300 (2001) 1e-112  
21
15PR
15RT
0 Case report(s) / study subset
Blick (2006) THE Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1-Infected Patient J. Infect. Dis. 195 (9), 1250-1259 (2007) 1e-163  
13
1PR
13RT
0 Case report(s) / study subset
Bobkov (2004) DIVERSITY of HIV-1 Subtype A and CRF03_AB Protease in Eastern Europe: Selection of the V77I Variant Followed by Its Rapid Spread in IDU Populations Unpublished 5e-40 27
27PR
30
30PR
90 HIVDB
Bodelle (2004) IDENTIFICATION and Genomic Sequence of an HIV Type 1 Group N Isolate from Cameroon AIDS Res. Hum. Retroviruses 20 (8), 902-908 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Boeri (2003) EVOLUTIONARY characteristics of HIV-1 variants resistant to protease inhibitors in the absence of drug-selective pressure AIDS Res. Hum. Retroviruses (2003) In press 0  
18
18PR
18RT
0 Case report(s) / study subset
Bogh (2001) INVESTIGATING association between baseline HIV-1 genotypic resistance and virological response among protease in-hibitor-naive patients treated with HAART Unpublished 1e-133  
180
112PR
68RT
0 Unpublished
Bolivar (2009) The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain J. Acquir. Immune Defic. Syndr. 52 (5), 659-661 (2 1e-161  
1
1IN
0 Case report(s) / study subset
Bonhoeffer (2008) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 1e-175 8676
8676PR
8676RT
8676
5624PR
7806RT
100 HIVDB
Bonhoeffer (2010) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 9e-49 8
8PR
8RT
8
8PR
100 HIVDB
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. (2011) In press 2e-50 32
32PR
32RT
32
32PR
100 HIVDB
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. (2011) In press 2e-48 1
1PR
1RT
1
1PR
100 HIVDB
Bonura (2010) Transmission of drug-resistant HIV-1 strains in HAART-naive patients: a five-year retrospective study in Sicily, Italy Unpublished 0 109
109PR
109RT
109
41PR
109RT
100 HIVDB
Bouchard (2004) HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses 23 (3), 482-485 (2007) 1e-140 37
17PR
20RT
37
17PR
20RT
100 HIVDB
Bourara (2007) TARGET cell APOBEC3C can induce limited G-to-A mutation in HIV-1 PLoS Pathog. 3 (10), 1477-1485 (2007) 4e-52  
2
2PR
0 Case report(s) / study subset
Bouzeghoub (2005) HIGH Diversity of HIV Type 1 in Algeria AIDS Res. Hum. Retroviruses 22 (4), 367-372 (2006) 1e-149 248
133PR
116RT
248
132PR
116RT
100 HIVDB
Bouzeghoub (2008) FIRST Observation of HIV Type 1 Drug Resistance Mutations in Algeria AIDS Res. Hum. Retroviruses 24 (11), 1467-1473 (2008) 1e-148  
37
16PR
21RT
0 Pending
Brachtel (2002) DEMONSTRATION of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils AIDS Res. Hum. Retroviruses 18 (11), 785-790 (2002) 1e-62  
43
43PR
0 Evolution/quasispecies study
Bradshaw (2007) NOVEL Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Antimicrob. Agents Chemother. 51 (12), 4489-4491 (2007) 0 9
4PR
9RT
9
9RT
100 HIVDB
Brandin (2003) POL Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy AIDS Res. Hum. Retroviruses 19 (7), 543-550 (2003) 3e-97 30
30PR
30RT
30
30PR
30RT
100 HIVDB
Brann (2006) FUNCTIONAL Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness J. Virol. 80 (12), 6136-6145 (2006) 2e-49  
1
1PR
0 Case report(s) / study subset
Brehm (2011) Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase J. Acquir. Immune Defic. Syndr. 56 (4), 344-348 (2 0  
106
106RT
0 Pending
Brennan (1997) GENETIC variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma AIDS Res. Hum. Retroviruses 13 (5), 401-404 (1997) 0.27 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Brennan (2007) HIV-1 Strains Identified in Brazilian Blood Donors: Significant Prevalence of B/F1 Recombinants AIDS Res. Hum. Retroviruses 23 (11), 1434-1441 (2007) 1e-167 82
82IN
85
85IN
96 HIVDB
Brennan (2009) The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004 J. Acquir. Immune Defic. Syndr. 49 (4), 432-439 (2 1e-166 572
572IN
573
573IN
99 HIVDB
Brennan (2009) Identification of HIV-1 Non-B Subtypes and Antiretroviral Drug Resistant Strains in United States Blood Donors Unpublished 0 65
62PR
62RT
3IN
65
43PR
62RT
3IN
100 HIVDB
Brennan (2011) Expanded Evaluation of Blood Donors in the United States for HIV-1 Non-B Subtypes and Antiretroviral Drug Resistant Strains: 2005-2007 Unpublished 0  
25
8PR
25RT
0 Pending
Brenner (2006) HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture AIDS 20 (9), F9-F13 (2006) 0  
5
3PR
5RT
0 Pending
Brenner (2006) HIGH Rates of Forward Transmission Events after Acute/Early HIV-1 Infection J. Infect. Dis. 195 (7), 951-959 (2007) 0  
24
22PR
12RT
0 Case report(s) / study subset
Brenner (2010) HIV-1 Integrase Genotypic Analysis: Implications in the Study of HIV-1 Drug Resistance and Subtype Diversification Antimicrob. Agents Chemother. (2010) In press 0  
8
7RT
8IN
0 Unpublished
Brenner (2011) Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors J. Med. Virol. 83 (5), 751-759 (2011) 1e-167  
149
149IN
0 Pending
Brenner (2011) Spread of HIV-1 Drug-Resistant Sub-epidemics Unpublished 0  
1
1RT
0 Unpublished
Brigido (2005) SHORT Communication: Molecular Characteristics of HIV Type 1 Circulating in Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 21 (7), 673-682 (2005) 0  
174
68PR
106RT
0 Pending
Brigido (2008) HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil AIDS Res. Hum. Retroviruses 23 (12), 1579-1586 (2007) 0 149
103PR
99RT
149
65PR
97RT
100 HIVDB
Brigido (2010) Southern Brazil HIV Type 1 C Expansion into the State of Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 27 (3), 339-344 (2011) 0  
247
192PR
69RT
15IN
0 Pending
Brindeiro (1999) SEQUENCE diversity of the reverse transcriptase of human immunodeficiency virus type-1 from Brazilian untreated individuals Antimicrob. Agents Chemother. (1999) In press 2e-91 18
18RT
18
18RT
100 HIVDB
Brindeiro (2003) BRAZILIAN Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals AIDS 17 (7), 1063-1069 (2003) 1e-145 350
199PR
191RT
357
199PR
199RT
98 HIVDB
Briones (2000) DYNAMICS of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy Virus Res. 66 (1), 13-26 (2000) 1e-128  
186
180PR
186RT
0 Evolution/quasispecies study
Briones (2003) MEMORY in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus J. Mol. Biol. 331 (1), 213-229 (2003) 1e-126  
15
15PR
15RT
0 Evolution/quasispecies study
Brown (2009) Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions J. Infect. Dis. 199 (3), 427-431 (2009) 1e-172  
160
133PR
77RT
0 Evolution/quasispecies study
Brown (1999) SEQUENCE clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy J. Infect. Dis. 180 (4), 1043-1049 (1999) 1e-130  
55
55PR
55RT
0 DNAChip
Brown (2005) BIOLOGIC and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines J. Virol. 79 (10), 6089-6101 (2005) 0 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Brumme (2007) EVIDENCE of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 PLoS Pathog. 3 (7), E94 (2007) 0 811
811PR
594RT
811
773PR
594RT
100 HIVDB
Brumme (2009) HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins PLoS ONE 4 (8), E6687 (2009) 0 1139
543PR
537RT
975IN
1285
415PR
691RT
1129IN
88 HIVDB
Bruselles (2009) Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV BF recombinant associated with a fatal primary infection AIDS Res Hum Retroviruses. 2009 Sep;25(9):937-42. 0  
1
1PR
1RT
1IN
0 Pending
Buckton (2008) DEVELOPMENT and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance J. Antimicrob. Chemother. 62 (6), 1191-1198 (2008) 0  
17
17RT
0 Case report(s) / study subset
Bulgheroni (2001) UNUSUAL codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility J. Clin. Virol. 29 (1), 27-32 (2004) 4e-77  
3
3RT
0 Pending
Buonaguro (2006) SCREENING of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy J. Acquir. Immune Defic. Syndr. 37 (2), 1295-1306 (2004) 0  
3
3RT
3IN
0 Case report(s) / study subset
Burda (2005) HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common AIDS Res. Hum. Retroviruses 20 (12), 1358-1363 (2004) 2e-50  
17
17PR
0 Sequence quality
Burda (2010) HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon J. Med. Virol. 82 (2), 187-196 (2010) 1e-156 1
1RT
1
1RT
100 HIVDB
Burkala (2005) COMPARTMENTALIZATION of HIV-1 in the central nervous system: role of the choroid plexus AIDS 19 (7), 675-684 (2005) 1e-152  
140
123PR
140RT
0 Evolution/quasispecies study
Burns (2005) SEQUENCE variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes AIDS Res. Hum. Retroviruses 18 (14), 1031-1041 (2002) 1e-159 21
21IN
21
21IN
100 HIVDB
Bussmann (2005) HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana Unpublished 0 71
71PR
71RT
71
64PR
71RT
100 HIVDB
Buzon (2011) Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes J. Acquir. Immune Defic. Syndr. (2011) In press 4e-50  
8
8PR
0 Evolution/quasispecies study
Bychenko (2009) Isolation and characterization of new HIV-1 subtype A1 strain from Russia, envelope proteins variability analysis Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Byrn (2006) HIV-1 in semen: an isolated virus reservoir Lancet 350 (9085), 1141 (1997) 4e-52  
35
35PR
0 Evolution/quasispecies study
Cabana (1999) EMERGENCE and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors J. Med. Virol. 59 (4), 480-490 (1999) 1e-125 92
54PR
38RT
92
54PR
38RT
100 HIVDB
Cabrera (2008) RALTEGRAVIR Susceptibility and Fitness Progression of HIV-1 Integrase in Patients on Long-Term Antiretroviral Therapy Unpublished 1e-167 135
135IN
135
135IN
100 HIVDB
Calazans (2003) LOW Accumulation of L90M in Protease from Subtype F HIV-1 with Resistance to Protease Inhibitors Is Caused by the L89M Polymorphism J. Infect. Dis. 191 (11), 1961-1970 (2005) 1e-126 51
51PR
51RT
52
52PR
51RT
98 HIVDB
Cali (2004) EVIDENCE for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort AIDS Res. Hum. Retroviruses 21 (8), 728-733 (2005) 0  
15
15PR
15RT
15IN
0 Case report(s) / study subset
Calugi (2006) ENTIRE Genome of a Strain of Human Immunodeficiency Virus Type 1 with a Deletion of nef That Was Recovered 20 Years after Primary Infection: Large Pool of Proviruses with Deletions of env J. Virol. 80 (23), 11892-11896 (2006) 0  
1
1RT
1IN
0 Sequence quality
Calvez (2002) IMPACT of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial Antivir. Ther. (Lond.) 7 (3), 211-218 (2002) 2e-94  
26
26RT
0 ARV Rx and/or other data are N/A
Candotti (1999) AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection J. Med. Virol. 62 (1), 1-8 (2000) 1e-165  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Canducci (2008) DYNAMIC patterns of Human immunodeficiency virus type 1 (HIV-1) integrase gene evolution in patients failing Raltegravir based salvage therapies Unpublished 1e-154 37
37IN
37
37IN
100 HIVDB
Cao (2007) HIV subtype distribution in a cohort of HIV infected Ugandans: clinical implications Unpublished 0 46
45PR
46RT
46
26PR
46RT
100 HIVDB
Cardoso (2009) HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil J. Clin. Virol. 46 (2), 134-139 (2009) 1e-145 76
76PR
76RT
76
76PR
8RT
100 HIVDB
Cardoso (2009) High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil AIDS Res. Hum. Retroviruses 25 (10), 943-950 (2009 1e-145 25
25PR
25RT
25
25PR
1RT
100 HIVDB
Cardoso (2010) HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil J. Med. Virol. 82 (3), 351-357 (2010) 1e-144  
62
62PR
4RT
0 Pending
Cardoso (2011) Molecular Characteristics of HIV Type 1 Infection Among Prisoners from Central Western Brazil AIDS Res. Hum. Retroviruses (2011) In press 2e-52  
18
18PR
0 Pending
Caride (2000) DRUG-RESISTANT reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART Virology 275 (1), 107-115 (2000) 5e-89  
14
14RT
0 ARV Rx and/or other data are N/A
Caride (2001) GENOTYPIC and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART Virus Genes 23 (2), 193-202 (2001) 1e-123 14
14PR
28
28PR
50 HIVDB
Carneiro-Proietti (1997) DIRECT Submission Submitted (14-NOV-1996) Lab. Virus, Dept. Microbiologia, Uni 1e-128  
1
1PR
0 Case report(s) / study subset
Caron (2008) HUMAN immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa AIDS Res. Hum. Retroviruses 24 (9), 1225-1228 (2008) 2e-50 4
4PR
4
4PR
100 HIVDB
Carr (1996) FULL-LENGTH sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand J. Virol. 70 (9), 5935-5943 (1996) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Carr (1998) FULL genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants Virology 247 (1), 22-31 (1998) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Carr (1999) CHARACTERIZATION of subtype A HIV-1 from Africa by full genome sequencing AIDS 13 (14), 1819-1826 (1999) 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (1999) DIRECT Submission Submitted (07-JUL-1998) Molecular Epidemiology, Henry M. Jac 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Carr (2001) THE AG Recombinant IbNG and Novel Strains of Group M HIV-1 are Common in Cameroon Virology (2001) In press 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (2001) DIVERSE BF recombinants have spread widely since the introduction of HIV-1 into South America AIDS 15 (15), F41-F47 (2001) 1e-165 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Carr (2004) OUTBREAK of a West African recombinant of HIV-1 in Tashkent, Uzbekistan J. Acquir. Immune Defic. Syndr. 39 (5), 570-575 (2005) 0 245
233PR
232RT
12IN
246
242PR
241RT
12IN
99 HIVDB
Carr (2005) HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria Unpublished 0 23
23PR
23RT
7IN
23
9PR
23RT
7IN
100 HIVDB
Carr (2006) FIRST report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina Unpublished 0 10
10PR
10RT
10IN
10
9PR
10RT
10IN
100 HIVDB
Carr (2006) HIGH Genetic Complexity of HIV-1 in low-prevalence, rural regions of Cameroon Unpublished 0 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Carr (2008) HIV-1 in the Caribbean is Dominated by Subtype B PLoS One. 2009;4(3):e4814. Epub 2009 Mar 12. 1e-139  
62
59PR
27RT
0 Pending
Carr (2008) IDENTIFICATION of CRF17_BF in Four South American Countries Unpublished 0  
6
1PR
6RT
6IN
0 Pending
Carr (2008) HIV-1 Epidemic in the Caribbean is Dominated by Subtype B Unpublished 0  
15
10PR
15RT
15IN
0 Pending
Carr (2010) HIV-1 Recombinants with Multiple Parental Strains in Low-Prevalence, Remote Regions of Cameroon Retrovirology. 2010 Apr 28;7:39. 0 24
24PR
23RT
24IN
24
24RT
24IN
100 HIVDB
Carrera (2010) Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo AIDS Res. Hum. Retroviruses 26 (7), 815-820 (2010) 0.002  
1
1IN
0 Gene fragment(s)
Carrion (2002) CIRCULATING Recombinant Form CRF02_AG in South America AIDS Res. Hum. Retroviruses 19 (4), 329-332 (2003) 1e-163 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Carrion (2004) DOCUMENTATION of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay AIDS Res. Hum. Retroviruses 20 (9), 1022-1025 (2004) 0 2
2PR
2RT
2IN
7
7PR
7RT
2IN
28 HIVDB
Carrion (2009) Molecular characterization of the human immunodeficiency virus type 1 among children in Lima, Peru AIDS Res. Hum. Retroviruses (2009) In press 1e-173  
2
2RT
0 Pending
Carvalho (2010) Primary Drug Resistance And HIV-1 Phylogenetic Diversity In North Brazil, Tocantins State Unpublished 1e-144 30
30PR
30RT
31
31PR
1RT
96 HIVDB
Carvalho (2010) Secondary Drug Resistance And HIV-1 Phylogenetic Diversity In North Brazil, Tocantins State Unpublished 4e-51  
5
5PR
0 Unpublished
Carvalho (2011) Moderate prevalence of primary drug resistance and interiorization of HIV-1 subtype C in the inland north state of Tocantins, Brazil AIDS Res. Hum. Retroviruses (2011) In press 3e-52 9
9PR
9RT
9
9PR
100 HIVDB
Casado (2003) NEAR Full-Length Genome Characterization of an HIV Type 1 CRF05_DF Virus from Spain AIDS Res. Hum. Retroviruses 19 (8), 719-725 (2003) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Casado (2005) DIRECT Submission Submitted (18-JAN-2005) Patogenia Viral, Instituto de Salud 1e-126  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Casado (2007) IDENTIFICATION of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba J. Acquir. Immune Defic. Syndr. 40 (5), 532-537 (2005) 0 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Castelbranco (2010) Frequency of Primary Resistance to Antiretroviral Drugs and Genetic Variability of HIV-1 Among Infected Pregnant Women Recently Diagnosed in Luanda-Angola AIDS Res. Hum. Retroviruses 26 (12), 1313-1316 (20 2e-49 2
2PR
2RT
2
2PR
100 HIVDB
Castillo (2009) Surveillance of HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses (2009) In press 1e-150 89
54PR
35RT
89
54PR
35RT
100 HIVDB
Castro (2002) MOLECULAR epidemiology of HIV-1 in Venezuela: high prevalence of HIV-1 subtype B and identification of a B/F recombinant infection J. Acquir. Immune Defic. Syndr. 32 (3), 338-344 (2003) 7e-77  
2
1PR
1RT
0 Case report(s) / study subset
Castro (2004) BODY Compartments Follow-up & HIV-1 Mosaic Genome Definition. E7109254 (in) EXTENDED ABSTRACT BOOK, XV INTERNATIONAL AIDS CONFERENC 1e-135  
4
4RT
0 Case report(s) / study subset
Castro (2004) RESISTANCE mutations and molecular characterization of HIV-1 isolates from Venezuelan patients with virological failure Unpublished 1e-136  
41
20PR
21RT
0 Pending
Castro (2009) HIV-1 transmission network of 103N resistance mutation in Southwest Switzerland AIDS Res Hum Retroviruses. 2010 Sep 23. [Epub ahead of print 0  
19
14PR
10RT
0 Evolution/quasispecies study
Caumont (2001) SEQUENCE analysis of Env C2/V3, Gag p17/p24, and Prot regions of 25 HIV-1 isolates from Ho Chi Minh City, Viet Nam Unpublished 9e-98 26
24PR
2RT
27
25PR
2RT
96 HIVDB
Ceballos (2009) HIV dual infection with subtype B and BF recombinants in Argentina Unpublished 1e-146  
45
38PR
11RT
0 Pending
Ceccherini-Silberstein (2005) IDENTIFICATION of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure AIDS 18 (12), F11-F19 (2004) 0  
477
242PR
477RT
0 Pending
Ceccherini-Silberstein (2006) HIGH sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations J. Virol. 79 (16), 10718-10729 (2005) 0  
178
123PR
178RT
0 Pending
Ceccherini-Silberstein (2007) IMPACT of HIV-1 Reverse Transcriptase Polymorphism F214L on Virological Response to Thymidine Analogue-Based Regimens in Antiretroviral Therapy (ART)-Naive and ART-Experienced Patients J. Infect. Dis. 196 (8), 1180-1190 (2007) 0  
275
255PR
88RT
0 Pending
Ceccherini-Silberstein (2007) CHARACTERIZATION and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors J. Virol. 81 (20), 11507-11519 (2007) 0  
75
44PR
75RT
0 ARV Rx and/or other data are N/A
Ceccherini-Silberstein (2007) Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients J. Infect. Dis. 196 (8), 1180-1190 (2007) 2e-48  
7
7PR
0 Pending
Ceccherini-Silberstein (2010) Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors Antimicrob. Agents Chemother. 54 (9), 3938-3948 (2 0  
457
429RT
457IN
0 Evolution/quasispecies study
Cenci (1997) SELECTED nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL AIDS Res. Hum. Retroviruses 13 (7), 629-632 (1997) 5e-49  
1
1RT
0 Case report(s) / study subset
Cenci (2003) LOW Intra-Host Diversity in HIV-1 Protease Gene in Untreated Primary Infection: a Crucial Role for Purifying Selection Unpublished 1e-126  
67
67PR
0 Unpublished
Cenci (2004) HIV-1 pol genotype divergence in the plasma and cerebrospinal fluid (CSF) of untreated patients in acute and chronic infection Unpublished 1e-108  
58
44PR
14RT
0 Unpublished
Chaix (2003) STABLE prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with HIV-1 primary infection in France Unpublished 1e-116 244
244RT
244
244RT
100 HIVDB
Chakrabarti (1999) SEQUENCE of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses Nature 328 (6130), 543-547 (1987) 1e-98 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Chakrabarti (2011) HIV-1 recombinants among Maipur IDUs Unpublished 0  
1
1RT
1IN
0 Unpublished
Chakraborty (2003) FAILURE to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus AIDS Res. Hum. Retroviruses 20 (9), 1026-1031 (2004) 0  
162
81PR
81RT
0 Evolution/quasispecies study
Chakraborty (2003) CAN HIV-1 superinfection compromise antiretroviral therapy? AIDS 18 (1), 132-134 (2004) 2e-87  
8
8RT
0 Case report(s) / study subset
Chaloin (2004) ANTIVIRAL activity of reverse trancriptase inhibitors with different HIV strains and isolates Unpublished 0  
14
14RT
8IN
0 ARV Rx and/or other data are N/A
Chamberland (2007) CHARACTERIZATION of drug resistance in a cohort of subjects on antiretroviral therapy infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso Unpublished 0 88
88PR
88RT
88
11PR
88RT
100 HIVDB
Chamberland (2011) HIV-1 primary drug resistance prevalence in Cotonou, Benin Unpublished 0 127
127PR
127RT
127
6PR
127RT
100 HIVDB
Chang (2006) MOLECULAR Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07)BC Infection in Intravenous Drug Users AIDS Res. Hum. Retroviruses 22 (11), 1055-1066 (2006) 1e-145 152
152PR
152RT
152
128PR
146RT
100 HIVDB
Chang (2008) Molecular Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07_BC Infection in Intravenous Drug Users Unpublished 5e-49 3
3PR
3RT
3
3PR
100 HIVDB
Chang (2000) DIFFERENTIAL stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses AIDS Res. Hum. Retroviruses 15 (17), 1591-1596 (1999) 1e-163  
5
5PR
5RT
5IN
0 Case report(s) / study subset
Chang (2000) SEQUENCE features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A AIDS Res. Hum. Retroviruses 15 (18), 1703-1706 (1999) 1e-163  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Chantratita (1999) HIV-1 resistant to antiretroviral drugs in Thailand Unpublished 1e-128  
722
342PR
469RT
0 ARV Rx and/or other data are N/A
Chaplin (2011) Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy AIDS Res. Hum. Retroviruses 27 (1), 71-80 (2011) 1e-168 2
2PR
2RT
2
2RT
100 HIVDB
Charpentier (2009) Prevalence of HIV-1 drug resistance in HIV-1 infected patients treated in Douala, Cameroon Unpublished 0  
56
1PR
56RT
0 Pending
Charpentier (2011) High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger Unpublished 1e-154 29
29RT
29
29RT
100 HIVDB
Charpentier (2011) Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir Unpublished 1e-100  
12
12IN
0 Pending
Charpentier (2011) Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen Unpublished 1e-166  
9
9IN
0 Pending
Chaturbhuj (2010) Human Immunodeficiency Virus Type 1 Transmitted Drug Resistance Threshold Surveillance among Newly HIV Type-1 diagnosed Drug Naive Clients attending Voluntary Counseling and Testing (VCT) sites in Mumbai, India Unpublished 0 34
34PR
34RT
34
34RT
100 HIVDB
Chen (2010) Near full-length genomic characterization of a novel HIV-1 CRF07_ BC/CRF08_ BC recombinant strain from Yunnan, China AIDS Res. Hum. Retroviruses (2010) In press 0  
1
1RT
1IN
0 Pending
Chen (1996) GENETIC characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop J. Virol. 70 (6), 3617-3627 (1996) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Cheng (1992) MOLECULAR characterization of HIV-2 (ROD) protease following PCR cloning from virus infected H9 cells Adv. Exp. Med. Biol. 312, 83-88 (1992) 2e-24  
1
1PR
0 Laboratory/experimental isolate
Chin (2006) INVERSE Relationship between Viral Load and Genotypic Resistance Mutations in Korean Patients with Primary HIV Type 1 Infections AIDS Res. Hum. Retroviruses 22 (11), 1142-1147 (2006) 1e-147 52
52PR
52RT
52
49PR
52RT
100 HIVDB
Chin (2007) EARLY identification of seronegative human immunodeficiency virus type 1 infection with severe presentation J. Clin. Microbiol. 45 (5), 1659-1662 (2007) 1e-143  
3
3PR
3RT
0 Case report(s) / study subset
Chin (2007) FACTORS Associated with Short-term Clinical Parameters after Genotypic Resistance Assay in Korean Patients with HIV-1 Subtype B Virologic Failure J Korean Med Sci. 2009 Dec;24(6):1031-7. Epub 2009 Nov 7. 1e-146  
40
23PR
40RT
0 Pending
Chin (2010) Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China AIDS Res. Hum. Retroviruses 26 (2), 217-221 (2010) 1e-164 9
9PR
9RT
9
6PR
6RT
100 HIVDB
Chin (2010) Direct Submission Submitted (09-APR-2010) Aaron Diamond AIDS Researc 0  
1
1RT
1IN
0 Unpublished
Cho (2005) DIRECT Submission Submitted (26-APR-2005) Microbiology, University of Ulsan Co 0  
1
1PR
1RT
1IN
0 HIVDB
Cho (2005) FULL-LENGTH sequences of long-term slow progressor Unpublished 0  
6
5PR
6RT
6IN
0 HIVDB
Cho (2006) VARIATION of vif gene according to progression rate in Korean patients: association with KRG treatment Unpublished 0.02  
105
105IN
0 Gene fragment(s)
Cho (2006) HIV-1 Vif gene Unpublished 0.02  
75
75IN
0 Gene fragment(s)
Cho (2008) HIGH Frequency of Gross Deletions in the 5' LTR and gag Regions in HIV Type 1-Infected Long-Term Survivors Treated with Korean Red Ginseng AIDS Res. Hum. Retroviruses 24 (2), 181-193 (2008) 1e-52  
18
17PR
1IN
0 Case report(s) / study subset
Cho (2001) LONG-TERM intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed Int. Immunopharmacol. 1 (7), 1295-1305 (2001) 4e-96 16
16RT
37
37RT
43 HIVDB
Cho (2002) FREQUENCY of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea J. Clin. Microbiol. 40 (4), 1319-1325 (2002) 1e-118 22
22RT
23
6PR
22RT
95 HIVDB
Cho (2003) MOLECULAR epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990 Vox Sang. 92 (2), 113-120 (2007) 0 1
1PR
186
149PR
161RT
0 Evolution/quasispecies study
Cho (2005) FULL sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box AIDS Res. Hum. Retroviruses 21 (11), 961-964 (2005) 0  
1
1RT
1IN
0 Case report(s) / study subset
Cho (2006) HIGH frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng Curr. HIV Res. 4 (4), 447-457 (2006) 0.02  
3
3IN
0 Case report(s) / study subset
Cho (2010) Molecular epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990 Vox Sang. 92 (2), 113-120 (2007) 0  
6
5PR
6RT
6IN
0 Case report(s) / study subset
Cho (2010) Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV-1 AIDS Res. Hum. Retroviruses (2010) In press 0  
138
104PR
137RT
138IN
0 Evolution/quasispecies study
Choi (1997) HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant AIDS Res. Hum. Retroviruses 13 (4), 357-361 (1997) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Choi (2010) Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay J. Clin. Virol. (2010) In press 1e-174  
5
5PR
3RT
0 Case report(s) / study subset
Church (2007) HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D AIDS Res. Hum. Retroviruses 23 (6), 764-768 (2007) 0 47
47PR
47RT
47
7PR
47RT
100 HIVDB
Church (2009) Analysis of NVP resistance in Ugandan infants who were HIV-infected despite receiving single dose (SD) nevirapine (NVP) vs. SD NVP plus up to 6-weeks of daily NVP to prevent HIV vertical transmission Unpublished 0 49
49PR
49RT
49
15PR
49RT
100 HIVDB
Ciccozzi (2005) MOLECULAR Diversity of HIV in Albania J. Infect. Dis. 192 (3), 475-479 (2005) 0 66
66PR
66RT
66
63PR
66RT
100 HIVDB
Ciccozzi (2007) THE HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries AIDS Res. Hum. Retroviruses 24 (6), 771-779 (2008) 1e-143 33
33PR
33RT
33
33RT
100 HIVDB
Ciccozzi (2010) Genetic Diversity of HIV-1 in Montenegro AIDS Res. Hum. Retroviruses (2010) In press 0  
32
13PR
32RT
0 Pending
Cilla (2001) MOLECULAR evidence of homosexual transmission of HIV type 2 in Spain AIDS Res. Hum. Retroviruses 17 (5), 417-422 (2001) 7e-05  
4
4RT
0 Case report(s) / study subset
Cinque (2001) EFFECT of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid AIDS Res. Hum. Retroviruses 17 (5), 377-383 (2001) 1e-129 33
15PR
18RT
57
24PR
33RT
57 HIVDB
Claassen (2009) Direct Submission Submitted (16-NOV-2007) NHLS/University of Stellen 1e-150  
119
119RT
0 Unpublished
Clarke (2005) REVERSE transcriptase and protease sequences from HIV-1 non-subtype B infected persons in the United Kingdom Unpublished 0 274
118PR
156RT
497
334PR
379RT
55 HIVDB
Clavel (1996) MOLECULAR cloning and polymorphism of the human immune deficiency virus type 2 Nature 324 (6098), 691-695 (1986) 1e-98 2
1PR
1RT
2IN
2
2RT
2IN
100 HIVDB
Cleland (1996) EVOLUTION of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 (1), 6-1 1e-123  
370
370RT
0 Gene fragment(s)
Clevenbergh (2002) LONG-TERM virologic outcome in patients infected with multi-nucleoside analogue resistant HIV-1 Antivir. Ther. (Lond.) (2002) In press 1e-121 24
12PR
12RT
24
12PR
12RT
100 HIVDB
Clewley (1998) A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus J. Virol. 72 (12), 10305-10309 (1998) 1.1 1
1PR
1RT
1
1RT
100 HIVDB
Clewley (2001) DIRECT Submission Unpublished 0 1
1IN
1
1PR
1RT
1IN
100 HIVDB
Cloyd (1990) SPECTRUM of biological properties of human immunodeficiency virus (HIV-1) isolates Virology 174 (1), 103-116 (1990) 1e-164  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Collaco Veras (2011) Molecular Epidemiology of HIV-1 CRF02_AG in Cameroon and African Patients Living in Italy Unpublished 0  
52
3PR
52RT
0 Unpublished
Collman (2000) V3-INDEPENDENT determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate Unpublished 1e-163 1
1IN
1
1PR
1RT
1IN
100 Laboratory/experimental isolate
Colonno (2004) IDENTIFICATION of I50L as the Signature Atazanavir (ATV)Resistance Mutation in Treatment-Naive HIV-1Infected Patients Receiving ATV-Containing Regimens J. Infect. Dis. 189 (10), 1802-1810 (2004) 3e-51 12
12PR
12
12PR
100 HIVDB
Condra (1996) GENETIC correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor J. Virol. 70 (12), 8270-8276 (1996) 1e-130 421
421PR
421
421PR
100 HIVDB
Cong (2006) THE Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions J. Virol. 81 (6), 3037-3041 (2007) 1e-172  
4
4RT
0 Laboratory/experimental isolate
Coovadia (2008) PERSISTENT Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy Clin. Infect. Dis. (2009) In press 1e-168  
99
99RT
0 Pending
Corbet (1999) ENV sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area J. Virol. 74 (1), 529-534 (2000) 1e-147 1
1PR
1RT
1IN
2
1PR
1RT
2IN
50 HIVDB
Cornelissen (1997) POL gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D J. Virol. 71 (9), 6348-6358 (1997) 1e-126 42
42PR
42RT
42
42PR
42RT
100 HIVDB
Cornelissen (2000) SPREAD of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa J. Gen. Virol. 81 (Pt 2), 515-523 (2000) 2e-86 20
20PR
20RT
21
21PR
21RT
95 HIVDB
Courgnaud (1992) GENETIC differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque J. Virol. 66 (1), 414-419 (1992) 4.2 2
2PR
2RT
2IN
2
2RT
100 HIVDB
Courgnaud (2001) CHARACTERIZATION of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family J. Virol. 75 (2), 857-866 (2001) 1e-76 3
1PR
1RT
3IN
3
1PR
3RT
3IN
100 HIVDB
Courgnaud (2002) CHARACTERIZATION of a Novel Simian Immunodeficiency Virus with a vpu Gene from Greater Spot-Nosed Monkeys (Cercopithecus nictitans) Provides New Insights into Simian/Human Immunodeficiency Virus Phylogeny J. Virol. 76 (16), 8298-8309 (2002) 4e-97 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Courgnaud (2003) PARTIAL Molecular Characterization of Two Simian Immunodeficiency Viruses (SIV) from African Colobids: SIVwrc from Western Red Colobus (Piliocolobus badius) and SIVolc from Olive Colobus (Procolobus verus) J. Virol. 77 (1), 744-748 (2003) 1e-149 5
1PR
2RT
5IN
5
5RT
5IN
100 HIVDB
Courgnaud (2003) IDENTIFICATION of a New Simian Immunodeficiency Virus Lineage with a vpu Gene Present among Different Cercopithecus Monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon J. Virol. 77 (23), 12523-12534 (2003) 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Couto-Fernandez (2006) PHYLOGENETIC Analysis of Brazilian HIV Type 1 Subtype D Strains: Tracing the Origin of This Subtype in Brazil AIDS Res. Hum. Retroviruses 22 (2), 207-211 (2006) 0 5
5IN
10
3PR
5RT
5IN
50 HIVDB
Crandall (1999) PARALLEL evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection Mol. Biol. Evol. 16 (3), 372-382 (1999) 1e-121  
41
41PR
0 Evolution/quasispecies study
Crandall (1999) ADVANCES in understanding the evolution of HIV AIDS 13, S39-S47 (1999) 1e-102  
49
49PR
0 Evolution/quasispecies study
Crowell (2003) OPTIMIZATION of Oligonucleotide Ligation Assay for Detection of Drug Resistance Mutations in Non-Subtype B HIV-1 Unpublished 1e-133  
18
17PR
18RT
0 ARV Rx and/or other data are N/A
Cuevas (2010) Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men Euro Surveill. 14 (47) (2009) 0 92
92PR
92RT
92
41PR
88RT
100 HIVDB
Cuevas (2009) HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain J. Acquir. Immune Defic. Syndr. 51 (1), 99-103 (20 1e-52 233
233PR
233RT
233
233PR
100 HIVDB
Cuevas (2010) Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment AIDS Res Hum Retroviruses. 2010 Sep;26(9):1019-25 0  
28
7PR
28RT
28IN
0 Pending
Cunningham (2002) DEVELOPMENT of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of pediatric AIDS clinical trials group protocol 316 J. Infect. Dis. 186 (2), 181-188 (2002) 5e-92  
79
79RT
0 ARV Rx and/or other data are N/A
D'Arrigo (2007) GP41 Sequence Variability in HIV Type 1 Non-B Subtypes Infected Patients Undergoing Enfuvirtide Pressure AIDS Res. Hum. Retroviruses 23 (10), 1296-1302 (2007) 0  
3
3RT
0 Case report(s) / study subset
Damond (2004) POLYMORPHISM of HIV-2 protease gene and selection of drug resistance mutations in HIV-2 infected patients treated with protease inhibitors J. Clin. Microbiol. (2004) In press 5e-25  
94
94PR
0 Pending
Damond (2006) IDENTIFICATION of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification AIDS Res. Hum. Retroviruses 20 (6), 666-672 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Daniel (1993) SIMIAN immunodeficiency virus from African green monkeys J. Virol. 62 (11), 4123-4128 (1988) 1e-33  
1
1RT
0 Gene fragment(s)
Dash (2007) EXCEPTIONAL molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype-C infection Retrovirology 5 (1), 25 (2008) 0  
1
1RT
1IN
0 Case report(s) / study subset
Dau (2010) Connection domain mutations in treatment-experienced patients in the OPTIMA trial J. Acquir. Immune Defic. Syndr. 54 (2), 160-166 (2 0  
420
106PR
415RT
0 Pending
Daumer (2010) Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source AIDS Res. Hum. Retroviruses 26 (3), 275-278 (2010) 1e-166  
3
3RT
0 Evolution/quasispecies study
Dazza (2003) CHARACTERIZATION of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti) J. Virol. 79 (13), 8560-8571 (2005) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
De Arellano (2007) IMPACT of Ethnicity and HIV Type 1 Subtype on Response to First-Line Antiretroviral Therapy AIDS Res. Hum. Retroviruses 23 (7), 891-894 (2007) 1e-134  
10
10PR
1RT
0 Pending
de Baar (2001) NATURAL residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo AIDS Res. Hum. Retroviruses 16 (14), 1385-1394 (2000) 2e-17 5
5PR
5RT
5
5PR
5RT
100 HIVDB
de Felipe (2011) Prevalence and resistance mutations of HIV-1 non-B subtypes among immigrants in Southern Spain Unpublished 2e-51  
48
48PR
0 Unpublished
De Maio (2008) MOLECULAR characterization of the vif accessory gene of HIV-1 from perinatally infected children with different rates of disease progression Unpublished 0.032  
6
6IN
0 Gene fragment(s)
de Medeiros (2011) Co-circulation scenario of HIV1 subtypes B, C and CRF31BC in a drug naive population from southernmost Brazil: analysis of primary resistance mutation Unpublished 8e-52 41
41PR
41RT
41
41PR
100 HIVDB
de Mendoza (2005) RESISTANCE to non-nucleoside reverse transcriptase inhibitors and non-B subtypes are on the rise among recent HIV-1 infections in Spain Unpublished 0  
20
19PR
20RT
0 Case report(s) / study subset
de Mendoza (2009) Changes in drug resistance patterns following the introduction of HIV-1 non-B subtypes in Spain AIDS Res Hum Retroviruses. 2009 Oct;25(10):967-72 0  
135
9PR
134RT
0 Pending
de Mulder (2011) Drug resistance prevalence and HIV-1 variant characterization in naive and pretreated HIV-1 infected pedriatric population in Madrid, Spain Unpublished 0  
127
114PR
35RT
0 Pending
de Oliveira (2008) HIGH frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil Arch. Virol. 153 (10), 1799-1806 (2008) 0  
129
64PR
68RT
0 Pending
De Pasquale (2004) DIFFERENCES in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy Unpublished 0  
39
39PR
39RT
0 ARV Rx and/or other data are N/A
de Ronde (2001) ESTABLISHMENT of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus J. Virol. 75 (2), 595-602 (2001) 2e-91  
8
8RT
0 Case report(s) / study subset
De Sa-Filho (2008) HIV Type 1 pol Gene Diversity and Antiretroviral Drug Resistance Mutations in Santos, Brazil AIDS Res. Hum. Retroviruses (2008) In press 1e-154 83
83PR
83RT
83
31PR
83RT
100 HIVDB
de Silva (2010) HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form Retrovirology 7 (1), 82 (2010) 0 3
3PR
3RT
3IN
3
2RT
3IN
100 HIVDB
Deacon (1995) GENOMIC structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients Science 270 (5238), 988-991 (1995) 1e-161  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Deeks (1999) NOVEL four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome J. Infect. Dis. 179 (6), 1375-1381 (1999) 1e-127 15
15PR
15RT
16
16PR
16RT
93 HIVDB
Dehghani (2003) UNIQUE Pattern of Convergent Envelope Evolution in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques: Association with CD4-Independent Usage of CCR5 J. Virol. 77 (11), 6405-6418 (2003) 1e-101  
2
2RT
2IN
0 Laboratory/experimental isolate
Deho (2008) Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland AIDS Res. Hum. Retroviruses 24 (2), 323-325 (2008) 5e-50 12
12PR
12RT
12
12PR
100 HIVDB
Delaugerre (2003) SELECTION of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF J. Clin. Virol. 32 (3), 241-244 (2005) 1e-142 1
1RT
1
1RT
100 HIVDB
Delgado (2001) ANALYSIS of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study AIDS Res. Hum. Retroviruses 17 (8), 753-758 (2001) 1e-130 199
100PR
100RT
1IN
199
100PR
100RT
100 HIVDB
Delgado (2002) IDENTIFICATION of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure J. Acquir. Immune Defic. Syndr. 29 (5), 536-543 (2002) 2e-71 9
9PR
9RT
9IN
9
9PR
9RT
100 HIVDB
Delgado (2008) HIGH prevalence of unique recombinant forms of HIV-1 in Ghana: Molecular epidemiology from an antiretroviral resistance study Unpublished 0 199
199PR
199RT
199
2PR
199RT
100 HIVDB
Delgado (2008) High prevalence of unique recombinant forms of HIV-1 in Ghana: Molecular epidemiology from an antiretroviral resistance study Unpublished 1e-47 1
1PR
1RT
1
1PR
100 HIVDB
Delgado (2010) Identification of a new HIV-1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile AIDS Res Hum Retroviruses. 2010 Jul;26(7):821-6. 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Delobel (2004) EVIDENCE for compartmentalization of human immunodeficiency virus type 1 in different blood cell types during prolonged suppressive antiretroviral therapy Unpublished 1e-129  
212
212RT
0 Evolution/quasispecies study
Demarest (2009) Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism Antimicrob. Agents Chemother. 53 (3), 1116-1123 (2 1e-171  
16
10PR
15RT
0 Pending
Demeter (2000) DELAVIRDINE susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260) Antimicrob. Agents Chemother. 44 (3), 794-797 (2000) 4e-96 67
67RT
67
67RT
100 HIVDB
Demeter (2001) IMPACT of Clinical Reverse Transcriptase Sequences on the Replication Capacity of HIV-1 Drug-Resistant Mutants Unpublished 4e-96 15
15RT
15
15RT
100 HIVDB
Deng (2010) Molecular tracing of HIV type 1 transmission in Hainan province of China AIDS. 2009 May 15;23(8):977-85 0  
1
1RT
0 Unpublished
Derache (2006) GENETIC Diversity and Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 from Untreated Patients in Bamako, Mali Antivir. Ther. (Lond.) (2007) In press 1e-140 94
93PR
94RT
94
18PR
93RT
100 HIVDB
Derache (2008) EVOLUTION of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006 J. Antimicrob. Chemother. 62 (3), 456-463 (2008) 1e-145 110
110PR
110RT
110
7PR
105RT
100 HIVDB
Deroo (2002) HIV-1 subtypes in Luxembourg, 1983-2000 AIDS 16 (18), 2461-2467 (2002) 1e-133  
568
284PR
284RT
0 ARV Rx and/or other data are N/A
Desai (2008) DIRECT Submission Submitted (05-AUG-2008) Department of Neurovirology, Nationa 0  
1
1RT
1IN
0 Case report(s) / study subset
Desai (2009) HIV-2 isolate NNVB-HIV-2 from India, partial genome Unpublished 1e-24  
1
1IN
0 Pending
Desai (2000) MOLECULAR cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences Proc. Natl. Acad. Sci. U.S.A. 83 (21), 8380-8384 (1986) 6e-74  
1
1PR
0 Gene fragment(s)
Descamps (1997) SUSCEPTIBILITY of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses J. Virol. 71 (11), 8893-8898 (1997) 3e-19 10
10PR
10RT
10
10PR
10RT
100 HIVDB
Descamps (2011) Direct Submission Submitted (16-DEC-2010) Laboratoire de Virologie, 0  
136
136RT
0 Unpublished
Deshpande (2004) MOLECULAR characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations AIDS Res. Hum. Retroviruses 20 (9), 1032-1035 (2004) 1e-146 248
122PR
126RT
248
122PR
126RT
100 HIVDB
Deshpande (2009) Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008 AIDS Res. Hum. Retroviruses 25 (6), 633-635 (2009) 1e-150 86
86RT
86
86RT
100 HIVDB
Desire (2001) QUANTIFICATION of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay J. Clin. Microbiol. 39 (4), 1303-1310 (2001) 3e-15  
16
16IN
0 Gene fragment(s)
Devereux (1999) RAPID decline in detectability of HIV-1 drug resistance mutations after stopping therapy AIDS 13 (18), 123-127 (1999) 1e-128  
48
47PR
43RT
0 Evolution/quasispecies study
Devereux (1999) SUBSTANTIAL correlation between HIV-1 drug-associated resistance mutations detected in plasma and peripheral blood mononuclear cells in heavily treated patients Unpublished 1e-127  
76
38PR
38RT
0 Pending
Devereux (2000) REDUCTION in human immunodeficiency virus type 1 mutations associated with drug resistance after initiating new therapeutic regimens in pretreated patients J. Infect. Dis. 181 (5), 1804-1807 (2000) 1e-127  
80
40PR
40RT
0 Evolution/quasispecies study
Devereux (2000) IN vivo HIV-1 compartmentalisation: drug resistance-associated mutation distribution J. Med. Virol. 66 (1), 8-12 (2002) 1e-122  
213
122PR
91RT
0 Evolution/quasispecies study
Devereux (2001) REPLICATIVE fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations J. Med. Virol. 65 (2), 218-224 (2001) 1e-124  
27
27PR
27RT
0 Evolution/quasispecies study
Dewhurst (1993) SEQUENCE analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 Nature 345 (6276), 636-640 (1990) 1e-101 1
1PR
1RT
1IN
5
2RT
5IN
20 Laboratory/experimental isolate
Diallo (2003) THE M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates Antimicrob. Agents Chemother. 47 (7), 2376-2379 (2003) 1e-135  
6
3PR
3RT
0 Laboratory/experimental isolate
Diamond (2001) IDENTIFICATION of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection J. Biol. Chem. 276 (26), 23624-23631 (2001) 1.1  
1
1RT
0 Laboratory/experimental isolate
Diamond (2002) MONITORING Fidelity Change of Simian Immunodeficiency Virus Reverse Transcriptase (RT) During the Course of Viral Infection: A New RT Mutation Responsible for In Vivo RT Fidelity Change Unpublished 0.017  
2
2RT
0 Laboratory/experimental isolate
Diaz (2008) SELECTIVE regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic Virology 381 (2), 184-193 (2008) 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Dietrich (1997) A highly divergent HIV-2-related isolate Nature 342 (6252), 948-950 (1989) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Dieudonne (2005) HIGH prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates Invest. Clin. 47 (1), 27-34 (2006) 1e-145  
30
22PR
30RT
0 Pending
Dilernia (2007) HIV Type 1 Genetic Diversity Surveillance among Newly Diagnosed Individuals from 2003 to 2005 in Buenos Aires, Argentina AIDS Res. Hum. Retroviruses 23 (10), 1201-1207 (2007) 0 283
283PR
283RT
283
222PR
282RT
100 HIVDB
Diop-Ndiaye (2010) Antiretroviral Drug Resistance Mutations in antiretroviral-naive patients from 1998 to 2007 in Senegal AIDS Res Hum Retroviruses. 2010 Sep 19. [Epub ahead of print 0 122
122PR
122RT
122
5PR
122RT
100 HIVDB
Doualla-Bell (2007) HIGH prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens Antimicrob. Agents Chemother. 50 (12), 4182-4185 (2006) 1e-176 23
23RT
23
23RT
100 HIVDB
Dourado (2005) HIV in the general population of an urban center in northeast Brazil Unpublished 2e-51  
4
4PR
0 Case report(s) / study subset
Dowling (2002) FORTY-ONE near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants AIDS 16 (13), 1809-1820 (2002) 1e-166 41
41PR
41RT
41IN
41
41PR
41RT
41IN
100 HIVDB
Drexler (2006) RATES of and Reasons for Failure of Commercial Human Immunodeficiency Virus Type 1 Viral Load Assays in Brazil J. Clin. Microbiol. 45 (6), 2061-2063 (2007) 1e-143  
16
6PR
16RT
0 Case report(s) / study subset
Duan (2001) INHIBITION of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates J. Infect. Dis. 184 (10), 1336-1340 (2001) 5e-89  
2
2RT
0 Laboratory/experimental isolate
Dumans (2002) PREVALENCE of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil Antimicrob. Agents Chemother. 46 (9), 3075-3079 (2002) 1e-129 101
54PR
47RT
102
55PR
47RT
99 HIVDB
Dumans (2004) SYNONYMOUS Genetic Polymorphisms within Brazilian Human Immunodeficiency Virus Type 1 Subtypes May Influence Mutational Routes to Drug Resistance J. Infect. Dis. 189 (7), 1232-1238 (2004) 0 186
83PR
130RT
188
84PR
131RT
1IN
98 HIVDB
Dumans (2008) DISTINCT resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure Infect. Genet. Evol. 9 (1), 62-70 (2009) 0 118
118PR
88RT
118
67PR
65RT
100 HIVDB
Dunne (2001) COMPARISON of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs AIDS 15 (12), 1471-1475 (2001) 1e-124 17
17PR
17RT
17
17PR
17RT
100 HIVDB
Duque (2002) THERAPEUTICS failure: Portuguese Cohort Unpublished 1e-128 104
104RT
316
212PR
104RT
32 HIVDB
Duque (2002) HUMAN immunodeficiency virus type 1 M36TV insertion in protease sequence Unpublished 1e-78  
2
2PR
0 Pending
Dvali (2010) Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Infected Individuals in Georgia Unpublished 1e-49  
7
7PR
0 Unpublished
Dykes (2004) DETECTION of Minority Drug-Resistant Variants of HIV-1 During Virologic Failure of Zidovudine (ZDV), Lamivudine (3TC), and Indinavir (IDV) Unpublished 0  
270
270PR
212RT
0 Evolution/quasispecies study
Dzissyuk (2011) Direct Submission Submitted (16-DEC-2010) Science, Republican Center 8e-50  
2
2PR
0 Unpublished
Eberle (2008) SEQUENCE of a HIV-1 Subtype F that is underquantified by Roche COBAS TaqMan and COBAS Amplicor Virus Load Tests Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Edmonson (1998) EVOLUTION of a simian immunodeficiency virus pathogen J. Virol. 72 (1), 405-414 (1998) 4e-22  
1
1IN
0 Laboratory/experimental isolate
El Annaz (2010) Presence of drug resistance mutations among drug-naive patients in Morocco AIDS Res. Hum. Retroviruses (2010) In press 1e-148 59
48PR
11RT
59
48PR
11RT
100 HIVDB
El-Khatib (2011) Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa AIDS 24 (11), 1679-1687 (2010) 1e-167 54
47PR
54RT
54
10PR
54RT
100 HIVDB
Ellenberger (1997) GENETIC diversity of HIV-1 in Abidjan, Cote d'Ivoire Unpublished 7e-86 20
20PR
23
23PR
86 HIVDB
Ellis (2009) Increased detection of HIV-1 drug-resistance at primary diagnosis in peripheral blood cells compared to plasma Unpublished 0  
58
55PR
6RT
0 Unpublished
English (2011) Transmission of highly distinct HIV-1 variants from a single donor Unpublished 1e-152  
66
66RT
0 Unpublished
Eremin (2010) CRF02_A/G isolated from patient on HAART with NRTIs and NNRTIs high level resistance Unpublished 1e-178  
1
1RT
0 Unpublished
Eremin (2010) Genotyping HIV-1 isolated from HIV-infected children born to HIV-infected mothers Unpublished 0  
1
1RT
0 Unpublished
Eron (1998) RESISTANCE of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission AIDS 12 (15), F181-F189 (1998) 1e-130  
59
59PR
59RT
0 Pending
Escoto-Delgadillo (2007) DRUG-RESISTANCE mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico HIV Med. 6 (6), 403-409 (2005) 7e-51  
30
30PR
0 Case report(s) / study subset
Eshleman (2001) IMPACT of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study) J. Infect. Dis. 184 (7), 914-917 (2001) 1e-110 102
102PR
102RT
102
102PR
102RT
100 HIVDB
Eshleman (2001) ANALYSIS of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377) J. Infect. Dis. 183 (12), 1732-1738 (2001) 1e-129 229
229PR
229RT
229
229PR
229RT
100 HIVDB
Eshleman (2002) SURVIVAL of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012) J. Acquir. Immune Defic. Syndr. 31 (3), 327-330 (2002) 1e-112 54
54PR
54RT
54
54PR
54RT
100 HIVDB
Eshleman (2003) USE of uracil N-glycosylase (UNG) negative Escherichia coli to clone dUTP-containing HIV-1 DNA generated using a commercial HIV-1 genotyping system Unpublished 0  
20
20PR
20RT
0 ARV Rx and/or other data are N/A
Eshleman (2004) CHARACTERIZATION of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012) J. Acquir. Immune Defic. Syndr. 35 (2), 126-130 (2004) 0 178
178PR
178RT
178
178PR
178RT
100 HIVDB
Eshleman (2004) PERFORMANCE of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 Strains J. Clin. Microbiol. 42 (6), 2711-2717 (2004) 0 124
124PR
124RT
124
124PR
124RT
100 HIVDB
Eshleman (2004) COMPARISON of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012 AIDS Res. Hum. Retroviruses 20 (6), 595-599 (2004) 0 76
76PR
76RT
78
78PR
78RT
97 HIVDB
Eshleman (2005) LIMITED Evolution in the HIV Type 1 pol Region among Acute Seroconverters in Pune, India AIDS Res. Hum. Retroviruses 21 (1), 93-97 (2005) 0 29
29PR
29RT
33
33PR
33RT
87 HIVDB
Eshleman (2005) NEVIRAPINE (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP J. Infect. Dis. 192 (1), 30-36 (2005) 0 65
65PR
65RT
67
58PR
67RT
97 HIVDB
Eshleman (2005) DISTINCT patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012 J. Acquir. Immune Defic. Syndr. 40 (1), 24-29 (2005) 0  
81
80PR
81RT
0 Evolution/quasispecies study
Eshleman (2006) PHENOTYPIC drug resistance patterns in subtype A HIV-1 clones with non-nucleoside reverse transcriptase (NNRTI) resistance mutations AIDS Res. Hum. Retroviruses (2005) In press 0 35
35PR
35RT
35
31PR
35RT
100 HIVDB
Eshleman (2006) NEVIRIPINE Resistance in Malawian Infants AIDS. 2005 Dec 2;19(18):2167-9. 0  
78
54PR
78RT
0 Pending
Eshleman (2007) ANTIRETROVIRAL drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection AIDS 21 (9), 1165-1174 (2007) 0 195
195PR
195RT
195
186PR
195RT
100 HIVDB
Eshleman (2008) HIV-1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug naive African women with subtypes A, C, and D AIDS Res. Hum. Retroviruses (2007) In press 0 198
198PR
198RT
198
82PR
198RT
100 HIVDB
Eshleman (2009) Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay AIDS Res. Hum. Retroviruses 25 (3), 343-345 (2009) 1e-167 110
110IN
120
120IN
91 HIVDB
Eshleman (2009) Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda AIDS 27 (7), 845-852 (2009) 1e-169 104
104PR
104RT
104
82PR
54RT
100 HIVDB
Espinosa (2002) INTERSUBTYPE BF recombinants of HIV-1 in a population of injecting drug users in Argentina J. Acquir. Immune Defic. Syndr. 36 (1), 630-636 (2004) 1e-102 21
21PR
21RT
21
21PR
21RT
100 HIVDB
Esteves (2004) NATURAL variation of HIV-1 subtype G protease Unpublished 5e-52 51
51PR
55
55PR
53RT
92 HIVDB
Esteves (2007) FULL-LENGTH HIV-1 subtype G molecular clone Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Etiebet (2011) Tenofovir Disoproxil Fumarate based regimens associated with less nucleoside reverse transcriptase inhibitors drug resistance mutations in Nigerian patients failing first-line anti-retroviral therapy Unpublished 1e-52  
15
15PR
0 Unpublished
Eyer-Silva (2002) REMISSION of HIV-associated myelopathy after initiation of lopinavir in a patient with extensive previous exposure to highly active antiretroviral therapy AIDS 16 (17), 2367-2369 (2002) 4e-47  
1
1PR
0 Case report(s) / study subset
Eyer-Silva (2006) MOLECULAR epidemiology of HIV-1 infection in a small Brazilian county: usefulness of envelope and polymerase sequences to epidemiologic studies J. Acquir. Immune Defic. Syndr. 41 (5), 664-670 (2006) 1e-136  
54
15PR
54RT
0 Pending
Eyer-Silva (2007) MOLECULAR Epidemiology of HIV Type 1 in Inner Rio De Janeiro State, Brazil AIDS Res. Hum. Retroviruses 23 (2), 303-308 (2007) 0 24
24PR
24RT
79
31PR
78RT
30 HIVDB
Eyer-Silva (2008) AUTOCHTHONOUS horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil Mem. Inst. Oswaldo Cruz 102 (7), 809-815 (2007) 0 9
9PR
9RT
9
8PR
1RT
100 HIVDB
Eyre (2006) MULTIPLE drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy Urology 55 (4), 591 (2000) 2e-52  
33
33PR
0 Evolution/quasispecies study
Eyzaguirre (2006) FIRST Molecular Surveillance Report of HIV Type 1 in Injecting Drug Users And Female Sex Workers along The U.S.-Mexico Border AIDS Res. Hum. Retroviruses 23 (2), 331-334 (2007) 1e-149  
11
10PR
11RT
0 Case report(s) / study subset
Eyzaguirre (2007) GENETIC Characterization of HIV-1 Strains Circulating in Kazakhstan J. Acquir. Immune Defic. Syndr. (2007) In press 0 75
75PR
75RT
6IN
75
73PR
6RT
6IN
100 HIVDB
Eyzaguirre (2011) Low HIV-1 viral load associated with increased prevalence of defective proviruses in Natural Viral Suppressors Unpublished 0  
46
36PR
46RT
46IN
0 Unpublished
Eyzaguirre (2011) Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay Unpublished 0  
25
14PR
25RT
25IN
0 Unpublished
Eyzaguirre (2011) Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations and the comparison with Acute HIV-1 Subtype B Infection Unpublished 0  
14
2PR
14RT
14IN
0 Unpublished
Falloon (2000) COMBINATION therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity Clin. Infect. Dis. 30 (2), 313-318 (2000) 1e-118 40
20PR
20RT
40
20PR
20RT
100 HIVDB
Fang (2000) GENETIC Variability of the HIV-1 Sequences from Plasma and Cervical Compartments Unpublished 1e-164  
42
42PR
42RT
18IN
0 Evolution/quasispecies study
Fang (2001) ANALYSIS of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1 AIDS Res. Hum. Retroviruses 17 (15), 1395-1404 (2001) 1e-163  
10
10PR
10RT
10IN
0 Case report(s) / study subset
Fang (2004) LONG-TERM Survivors in Nairobi: Complete HIV-1 RNA Sequences and Immunogenetic Associations J. Infect. Dis. 190 (4), 697-701 (2004) 0 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Fang (2002) PCR-MEDIATED recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA Nat. Med. 5 (2), 239-242 (1999) 1e-163  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Fang (2003) RECOMBINATION following superinfection by HIV-1 AIDS 18 (2), 153-159 (2004) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Fang (1995) UNIQUE insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells J. Virol. 69 (1), 75-81 (1995) 1e-164  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Farrar (1991) CHARACTERISATION of a series of human immunodeficiency virus isolates derived sequentially from a single patient J. Med. Virol. 34 (2), 104-113 (1991) 1e-163  
1
1PR
1RT
1IN
0 Evolution/quasispecies study
Federico (1989) BIOLOGIC and molecular characterization of producer and nonproducer clones from HUT-78 cells infected with a patient HIV isolate AIDS Res. Hum. Retroviruses 5 (4), 385-396 (1989) 1e-165  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Fernandez (2006) FITNESS Landscape of Human Immunodeficiency Virus Type 1 Protease Quasispecies J. Virol. 81 (5), 2485-2496 (2007) 1e-52  
295
295PR
0 Evolution/quasispecies study
Fernandez-Garcia (2008) DEVELOPMENT of a Panel of Well-Characterized Human Immunodeficiency Virus Type 1 Isolates from Newly Diagnosed Patients Including Acute and Recent Infections AIDS Res. Hum. Retroviruses 25 (1), 93-102 (2009) 0  
14
3PR
14RT
14IN
0 Case report(s) / study subset
Fernandez-Garcia (2009) Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia AIDS Res. Hum. Retroviruses 25 (11), 1187-1191 (20 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Fernandez-Garcia (2010) Identification of a new HIV-1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain AIDS Res. Hum. Retroviruses (2010) In press 0 4
4PR
4RT
2IN
7
4PR
7RT
2IN
57 HIVDB
Ferrari (2004) HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1 infected Ethiopians Hum. Immunol. 65 (6), 648-659 (2004) 8e-08  
11
11PR
0 Gene fragment(s)
Ferreira (2010) Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil AIDS Res. Hum. Retroviruses 26 (2), 229-232 (2010) 0 40
40PR
40RT
40
12PR
40RT
100 HIVDB
Finzi (1997) IDENTIFICATION of a reservoir for HIV-1 in patients on highly active antiretroviral therapy Science 278 (5341), 1295-1300 (1997) 1e-124  
12
12PR
12RT
0 Evolution/quasispecies study
Fischetti (2003) MOLECULAR epidemiology of HIV in Ghana: dominance of CRF02_AG J. Med. Virol. 73 (2), 158-166 (2004) 4e-85  
235
235RT
0 Gene fragment(s)
Fish (2010) Natural polymorphisms of integrase among HIV type 1-infected South African patients AIDS Res. Hum. Retroviruses 26 (4), 489-493 (2010) 1e-163 73
73IN
73
73IN
100 HIVDB
Fitzgibbon (1991) IN vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapy AIDS Res. Hum. Retroviruses 7 (3), 265-269 (1991) 3e-56  
18
18RT
0 Case report(s) / study subset
Fitzgibbon (1993) HUMAN immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs J. Virol. 67 (12), 7271-7275 (1993) 9e-94 23
23RT
23
23RT
100 HIVDB
Fitzgibbon (1993) A new type of G-->A hypermutation affecting human immunodeficiency virus AIDS Res. Hum. Retroviruses 9 (9), 833-838 (1993) 6e-67 2
2RT
2
2RT
100 HIVDB
Fitzgibbon (1993) HUMAN immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine Antimicrob. Agents Chemother. 36 (1), 153-157 (1992) 8e-54 17
17RT
17
17RT
100 HIVDB
Fitzgibbon (2001) EMERGENCE of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens AIDS Res. Hum. Retroviruses 17 (14), 1321-1328 (2001) 1e-126 51
28PR
23RT
51
28PR
23RT
100 HIVDB
Flaherty (1997) MOLECULAR and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus J. Virol. 71 (8), 5790-5798 (1997) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Fleury (2011) Drug resistance mutations in HIV-1 isolates from naive patients eligible for first line ART in JJ Hospital, Mumbai, India AIDS Res. Hum. Retroviruses (2011) In press 5e-50 5
5PR
5
5PR
100 HIVDB
Flores (1999) HIV-1 subtype F in single and dual infections in Puerto Rico: A potential sentinel site for monitoring novel genetic HIV variants in North America Emerging Infect. Dis. 5 (3), 481-483 (1999) 1e-130 19
19PR
19
19PR
100 HIVDB
Fomsgaard (1991) A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey Virology 182 (1), 397-402 (1991) 1e-113 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Fomsgaard (2008) FULL-LENGTH Characterization of A1/D Intersubtype Recombinant Genomes from a Therapy-Induced HIV Type 1 Controller during Acute Infection and His Noncontrolling Partner AIDS Res. Hum. Retroviruses 24 (3), 463-472 (2008) 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Fonjungo (2000) HUMAN immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features J. Clin. Microbiol. 40 (3), 837-845 (2002) 1e-121 110
110PR
111
111PR
99 HIVDB
Frahm (2006) INCREASED Sequence Diversity Coverage Improves Detection of HIV-Specific T Cell Responses J. Immunol. 179 (10), 6638-6650 (2007) 0  
8
6PR
8RT
8IN
0 Case report(s) / study subset
Franchini (1996) MOLECULAR and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone Proc. Natl. Acad. Sci. U.S.A. 86 (7), 2433-2437 (1989) 0.017 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Franchini (2004) SEQUENCE of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses Nature 328 (6130), 539-543 (1987) 0  
1
1RT
1IN
0 HIVDB
Frange (2008) NEW and Old Complex Recombinant HIV-1 Strains Among Patients with Primary Infection in 1996-2006 in France: the French ANRS CO06 Primo Cohort Study Unpublished 0  
2
2RT
2IN
0 Case report(s) / study subset
Frenkel (2002) MULTIPLE Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy J. Virol. 77 (10), 5721-5730 (2003) 1e-135  
979
777PR
801RT
0 Evolution/quasispecies study
Frenkel (2003) DRUG-RESISTANT mutants of human immunodeficiency virus type 1 persist at higher concentrations in peripheral blood mononuclear cells compared to plasma and are detected at a higher rate by OLA compared to consensus sequencing Unpublished 1e-136  
107
57PR
99RT
0 ARV Rx and/or other data are N/A
Fujisaki (2009) An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan AIDS Res. Hum. Retroviruses 25 (1), 15-21 (2009) 2e-52 107
107PR
107RT
107
107PR
100 HIVDB
Fukasawa (1999) SEQUENCE of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group Nature 333 (6172), 457-461 (1988) 1e-109 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Fumin (2002) CLONING and Characterization of a Virtually Full-Length HIV-1 Genome of a Prevalent Subtype B-Thai Strain in Central China Unpublished 1e-162  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Gafarova (2008) Direct Submission Submitted (19-NOV-2008) Biotechnology, The D.I. Iv 1e-166  
44
1PR
43IN
0 Unpublished
Gafarova (2009) The sequence of fragment of HIV-1 subtype G pol gene from Russia patient 0110 Unpublished 1e-177  
2
1RT
1IN
0 Case report(s) / study subset
Gafarova (2009) Full sequence of HIV-1 subtype G protease gene, isolated from Russia patient 104 Unpublished 5e-49  
1
1PR
0 Unpublished
Galkin (2004) FULL-LENGTH Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia AIDS Res. Hum. Retroviruses 22 (11), 1192-1197 (2006) 0 4
4PR
4RT
4IN
4
3PR
4RT
4IN
100 HIVDB
Galkin (2006) SEQUENCING and analysis of full-length HIV-1 CRF06_cpx isolate from Russia Unpublished 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Galkin (2009) The study of long-term HAART treatment effect for resistance-connected alterations in HIV-1 subtype B genes of 4 Austrian IDU patients Unpublished 0  
3
2PR
3RT
3IN
0 Case report(s) / study subset
Gallant (2005) EARLY Virologic Non-Response to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral Naive Subjects J. Infect. Dis. (2005) In press 1e-173 41
41PR
41RT
41
41PR
41RT
100 HIVDB
Galli (2007) RECOMBINATION analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms J. Gen. Virol. 89 (PT 12), 3119-3125 (2008) 1e-133  
28
27PR
4RT
0 Pending
Gandhi (2008) ROLE of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors J. Virol. 82 (6), 3125-3130 (2008) 0.027  
1
1IN
0 Gene fragment(s)
Gao (2001) RECOMBINATION in human immunodefeciency virus type 2 Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 Laboratory/experimental isolate
Gao (2003) COMPLETE genomes of HIV-1 subtype C viruses in South Africa Unpublished 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1999) ORIGIN of HIV-1 in the chimpanzee Pan troglodytes troglodytes Nature 397 (6718), 436-441 (1999) 1e-155 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (1996) MOLECULAR cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization J. Virol. 70 (3), 1651-1667 (1996) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1996) THE heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin J. Virology 70 (10), 7013-7029 (1996) 1e-164 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1998) AN isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I) J. Virol. 72 (12), 10234-10241 (1998) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (1998) A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 J. Virol. 72 (7), 5680-5698 (1998) 1e-166 8
8PR
8RT
8IN
8
8PR
8RT
8IN
100 HIVDB
Gao (2001) MOLECULAR characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo AIDS Res. Hum. Retroviruses 17 (12), 1217-1222 (2001) 1e-166 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (2001) EVIDENCE of two distinct subsubtypes within the HIV-1 subtype A radiation AIDS Res. Hum. Retroviruses 17 (8), 675-688 (2001) 1e-164 6
5PR
5RT
6IN
10
9PR
6RT
6IN
60 HIVDB
Gao (1992) HUMAN infection by genetically diverse SIVSM-related HIV-2 in west Africa Nature 358 (6386), 495-499 (1992) 5e-66 3
3RT
16
16RT
16IN
18 HIVDB
Gao (1993) GENETIC typing of HIV-2 from a Senegalese/German heterosexual transmission AIDS Res. Hum. Retroviruses 9 (7), 703-704 (1993) 2e-64  
2
2RT
2IN
0 Case report(s) / study subset
Gao (1994) GENETIC diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology J. Virol. 68 (11), 7433-7447 (1994) 1e-111 2
2RT
6
6RT
4IN
33 HIVDB
Garaev (2006) 5' region of HIV-1 G subtype pol gene Unpublished 1e-163  
79
3PR
79RT
0 Pending
Garaev (2007) DIRECT Submission Submitted (08-NOV-2006) Biotechnology, The D.I. Ivanovsky In 1e-161  
13
2PR
12RT
0 Pending
Garcia-Arriaza (2007) CHARACTERIZATION of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications Virus Res. 129 (2), 123-134 (2007) 2e-50  
3
3PR
0 Case report(s) / study subset
Garcia-Bujalance (2005) COMPARISON between Sequence Analysis and a Line Probe Assay for Testing Genotypic Resistance of Human Immunodeficiency Virus Type 1 to Antiretroviral Drugs J. Clin. Microbiol. 43 (8), 4186-4188 (2005) 1e-123 94
40PR
54RT
94
40PR
54RT
100 HIVDB
Garcia-Lerma (2001) INCREASED ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons Proc. Natl. Acad. Sci. U.S.A. 98 (24), 13907-13912 (2001) 5e-89  
7
7RT
0 Case report(s) / study subset
Garcia-Lerma (2004) TRANSMITTED Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of Zidovudine J. Virol. 78 (14), 7545-7552 (2004) 1e-142  
6
6RT
0 Case report(s) / study subset
Garcia-Vallejo (2009) Molecular epidemiology of Human immunodeficiency virus (HIV-1) antiviral resistance in isolates from patient of Colombian Caribbean Region Unpublished 0  
107
48PR
59RT
0 Unpublished
Garcia-Vallejo (2009) First Report of Human Immunodeficiency Virus type 2 (HIV-2) Infection in the Colombian Caribbean Region Unpublished 0  
3
3RT
0 Unpublished
Garrido (2009) Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection J. Antimicrob. Chemother. 65 (2), 320-326 (2010) 1e-166 418
418IN
418
418IN
100 HIVDB
Garrido (2010) Dynamics in the selection of resistance mutations in HIV patients failing Raltegravir and following its discontinuation Unpublished 1e-166  
53
53IN
0 Unpublished
Garriga (2010) HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations J. Antimicrob. Chemother. 64 (2), 251-258 (2009) 0  
153
76PR
147RT
0 Pending
Gashnikova (2011) Biological and Genetic Characterization of HIV-1 Strains Circulating in Siberia, Russia Unpublished 1e-176  
30
10PR
29RT
0 Unpublished
Gatanaga (1999) ACTIVE HIV-1 redistribution and replication in the brain with HIV encephalitis Arch. Virol. 144 (1), 29-43 (1999) 1e-52  
261
261RT
0 Evolution/quasispecies study
Gatanaga (1999) ANTI-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors AIDS Res. Hum. Retroviruses 15 (17), 1493-1498 (1999) 1e-126 15
15PR
15
15PR
100 HIVDB
Gatanaga (2000) DISCORDANCE between plasma- and PBMC-derived HIV-1 genotypes on protease inhibitor resistance Unpublished 1e-130  
70
70PR
0 ARV Rx and/or other data are N/A
Gatanaga (2011) Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan Antiviral Res. 75 (1), 75-82 (2007) 1e-165  
452
407PR
193RT
0 Pending
Geels (2003) IDENTIFICATION of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual J. Virol. 77 (23), 12430-12440 (2003) 0  
7
7PR
7RT
7IN
0 Case report(s) / study subset
Geels (2005) DIFFERENTIAL loss of human immunodeficiency virus type I (HIV-1)-specific T-helper responses in two HIV-1 infected individuals following CTL escape Unpublished 0  
5
5PR
5RT
5IN
0 Case report(s) / study subset
Gendelman (1987) MOLECULAR characterization of a polymerase mutant human immunodeficiency virus Virology 191 (1), 529 (1992) 1e-98  
3
3RT
0 Laboratory/experimental isolate
Geng (2010) Indinavir resistance pathway in one human immunodeficiency virus type 1 infected patient revealed by single-genome amplification Unpublished 0  
169
10PR
169RT
0 Unpublished
Georges-Courbot (1998) NATURAL infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus J. Virol. 72 (1), 600-608 (1998) 5e-71  
1
1IN
0 Pending
Ghosh (1998) HUMAN Immunodeficiency Virus type 1 complete genomic sequence Unpublished 1e-164  
1
1PR
1RT
1IN
0 HIVDB
Ghosh (1993) A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes Virology 194 (2), 858-864 (1993) 1e-164  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Giri (2000) CASE report of a novel amino acid deletion in codon 67 and T69G substitution in the RT of HIV-1 Unpublished 2e-76  
2
2RT
0 Case report(s) / study subset
Gittens (2002) THE Molecular Epidemiology and Drug Resistance Determination of HIV Type 1 Subtype B Infection in Barbados AIDS Res. Hum. Retroviruses 19 (4), 313-319 (2003) 1e-126 27
27PR
71
27PR
44RT
38 HIVDB
Giuliani (2008) NON-B HIV Type 1 Subtypes among Men Who Have Sex with Men in Rome, Italy AIDS Res. Hum. Retroviruses 25 (2), 157-164 (2009) 0  
116
64PR
116RT
0 Pending
Glenn (2006) A single amino acid change in gp41 is linked to the macrophage-only replication phenotype of a molecular clone of simian immunodeficiency virus derived from the brain of a macaque with neuropathogenic infection Virology 325 (2), 297-307 (2004) 8e-19  
1
1IN
0 Laboratory/experimental isolate
Goldberg (2009) Coinfection of Ugandan red colobus (Procolobus [Piliocolobus] rufomitratus tephrosceles) with novel, divergent delta-, lenti-, and spumaretroviruses J. Virol. 83 (21), 11318-11329 (2009) 2e-45  
3
3IN
0 Gene fragment(s)
Gomez-Carrillo (2004) DRUG Resistance Testing Provides Evidence of the Globalization of HIV Type 1: A New Circulating Recombinant Form AIDS Res. Hum. Retroviruses 20 (8), 885-888 (2004) 0 589
589PR
589RT
589
589PR
589RT
100 HIVDB
Gomez-Carrillo (2006) ANALYSIS of HIV Type 1 Diversity in Pregnant Women from Four Latin American and Caribbean Countries AIDS Res. Hum. Retroviruses 22 (11), 1186-1191 (2006) 0  
121
94PR
121RT
0 Pending
Gonzales (2002) EXTENDED spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors AIDS 17 (6), 791-799 (2003) 2e-97 287
287RT
287
287RT
100 HIVDB
Gonzales (2003) PROTEASE and Reverse Transcriptase Mutation Patterns in HIV Type 1 Isolates from Heavily Treated Persons: Comparison of Isolates from Northern California with Isolates from Other Regions AIDS Res. Hum. Retroviruses 19 (10), 909-915 (2003) 1e-173 100
38PR
62RT
100
38PR
62RT
100 HIVDB
Gonzales (2003) COLINEARITY of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing J. Acquir. Immune Defic. Syndr. 34 (4), 398-402 (2003) 0 82
7PR
75RT
82
8PR
75RT
100 HIVDB
Gonzalez Perez (2003) EPIDEMIOLOGICAL and molecular characteristics of HIV and HTLV infection in Equatorial Guinea Unpublished 1e-169 41
41RT
41
14PR
41RT
100 HIVDB
Gonzalez (2004) DETECTION of Human Immunodeficiency Virus Type 1 Antiretroviral Resistance Mutations by High-Density DNA Probe Arrays J. Clin. Microbiol. 42 (7), 2907-2912 (2004) 0  
178
89PR
91RT
0 ARV Rx and/or other data are N/A
Gonzalez (2009) Anti-Retroviral Therapy Resistance Mutations Present in the HIV Type 1 Subtype C pol and env Regions from Therapy Naive Patients in Zambia Unpublished 1e-175 50
50PR
50RT
67
1PR
66RT
74 HIVDB
Gonzalez (2010) Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia AIDS Res. Hum. Retroviruses 26 (7), 795-803 (2010) 1e-171  
55
13PR
55RT
0 Pending
Gordon (2002) MOLECULAR characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies J. Virol. 77 (4), 2587-2599 (2003) 2e-99 72
72PR
72RT
75
75PR
75RT
96 HIVDB
Gottlieb (2009) Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited west Africa Clin. Infect. Dis. 48, 476-483 (2009) 0  
169
169RT
0 Pending
Gottlieb (2011) HIV-2 Integrase Variation in Integrase Inhibitor-Naive Adults in Senegal, West Africa PLoS ONE 6 (7), E22204 (2011) 1e-101  
122
122IN
0 Pending
Goujon (2000) PHYLOGENETIC analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1 J. Virol. 74 (6), 2525-2532 (2000) 1e-137  
124
124RT
0 Evolution/quasispecies study
Graf (1998) CLONING and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China AIDS Res. Hum. Retroviruses 14 (3), 285-288 (1998) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Grant (2002) ACCURACY of the TRUGENE HIV-1 Genotyping Kit J. Clin. Microbiol. 41 (4), 1586-1593 (2003) 1e-128  
18
9PR
9RT
0 ARV Rx and/or other data are N/A
Grisson (2004) INFECTIOUS molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination J. Virol. 78 (24), 14066-14069 (2004) 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Grossman (2004) MUTATION D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir Antimicrob. Agents Chemother. 48 (6), 2159-2165 (2004) 4e-50 100
100PR
100
100PR
100 HIVDB
Guillon (1996) COMPLETION of nucleotide sequences of non-syncytium-inducing and syncytium-inducing HIV type 1 variants isolated from the same patient AIDS Res. Hum. Retroviruses 11 (12), 1537-1541 (1995) 1e-165  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Guimaraes (2008) IDENTIFICATION of two new CRF_BF in Rio de Janeiro State, Brazil AIDS 22 (3), 433-435 (2008) 0  
7
7RT
7IN
0 Case report(s) / study subset
Guimaraes (2009) Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates Retrovirology 6, 39 (2009) 0 9
4PR
9RT
4IN
9
9RT
4IN
100 HIVDB
Guimaraes (2010) Analysis of HIV-1 BF pr/rt recombinant strains from Rio de Janeiro/Brazil reveals multiple unrelated mosaic structures Infect. Genet. Evol. (2010) In press 1e-167  
24
24IN
0 Pending
Gunthard (1998) HUMAN immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy J. Virol. 72 (3), 2422-2428 (1998) 1e-128  
50
34PR
50RT
0 Evolution/quasispecies study
Gunthard (1999) HIGHER selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol Virology 259 (1), 154-165 (1999) 1e-130  
72
72PR
72RT
0 DNAChip
Guo (2008) Near Full-Length Genome Characterization of an HIV Type 1 CRF01_AE Strain from China Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Guo (2009) First detection of a novel HIV Type 1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China AIDS Res. Hum. Retroviruses 25 (4), 463-467 (2009) 0 3
3PR
3RT
1IN
3
1PR
3RT
1IN
100 HIVDB
Guo (2008) EMERGENCE of first HIV-1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China Unpublished 1e-168 11
11PR
11RT
12
11PR
8RT
91 Case report(s) / study subset
Gupta (2008) GENETIC Variations in the Vif Gene from HIV-1 Infected Individuals from North India Unpublished 0.028  
4
4IN
0 Gene fragment(s)
Gupta (2008) EVIDENCE for HIV-1 gag as a determinant of susceptibility to protease inhibitors using a full length subtype A and C gag-protease AIDS. 2010 Jul 17;24(11):1651-5. 0  
1
1RT
1IN
0 Pending
Gupta (2000) CLONING and Sequencing of HIV-1 Gag (B-subtype) from Indian Strain Unpublished 1e-16  
1
1PR
0 Gene fragment(s)
Gurgo (1988) ENVELOPE sequences of two new United States HIV-1 isolates Virology 164 (2), 531-536 (1988) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gurtler (1994) A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon J. Virol. 68 (3), 1581-1585 (1994) 1e-144 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gurusinghe (1995) REVERSE transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS J. Med. Virol. 46 (3), 238-243 (1995) 1e-89  
7
7RT
0 Case report(s) / study subset
Gutierrez (2003) PREVALENCE of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain J. Med. Virol. 74 (4), 521-527 (2004) 2e-49  
1
1PR
0 Case report(s) / study subset
Hachiya (2001) RAPID and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5) Antimicrob. Agents Chemother. 45 (2), 495-501 (2001) 1e-123  
45
25PR
20RT
0 ARV Rx and/or other data are N/A
Hachiya (2007) A novel mutation, N348I, in HIV-1 Reverse transcriptase confers 2-class cross resistance for RTIs Unpublished 0  
16
16RT
0 Pending
Hachiya (2010) A novel mutation, K70Q, in HIV-1 reverse transcriptase with Q151M enhances resistance to nucleoside RT inhibitors that remain active to Q151M complex Unpublished 0  
2
2RT
0 Unpublished
Haddad (2000) EVIDENCE for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells AIDS 14 (15), 2273-2281 (2000) 4e-96  
55
55RT
0 Evolution/quasispecies study
Hahn (1990) MOLECULAR characterization of an attenuated human immunodeficiency virus type 2 isolate Unpublished (1990) 6e-99 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Hamers (2010) HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia J. Acquir. Immune Defic. Syndr. (2010) In press 0 536
536PR
535RT
536
43PR
530RT
100 HIVDB
Hamers (2010) HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia J. Acquir. Immune Defic. Syndr. 55 (1), 95-101 (20 2e-47 1
1PR
1RT
1
1PR
100 HIVDB
Hamilton (2010) Partial pol sequence of HIV-1 in Jamaica Unpublished 1e-149  
37
30PR
22RT
0 Unpublished
Hamilton (2010) Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults Unpublished 7e-52  
54
54PR
0 Unpublished
Hamilton (2010) Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults Unpublished 1e-48  
1
1PR
0 Unpublished
Hamkar (2010) Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients AIDS 24 SUPPL 2, S85-S91 (2010) 0 28
28PR
28RT
28
1PR
27RT
100 HIVDB
Han (2009) Epidemiologic and Genetic Characterization of Human Immunodeficiency Virus Type I Infection In Liaoning Province, China J Acquir Immune Defic Syndr. 2010 Feb;53 Suppl 1:S27-33. 1e-163  
79
49PR
64RT
0 Pending
Han (2006) MOLECULAR Epidemiology of HIV in Liaoning Province, Northeastern China: Complex Findings in a Low Prevalence Area Unpublished 1e-170 88
88PR
72RT
88
74PR
72RT
100 HIVDB
Han (2009) Molecular analyses confirmed a HIV-1 heterosexual transmission chain in Guangzhou, China Unpublished 0  
4
2PR
4RT
0 Case report(s) / study subset
Handema (2002) PREVALENCE of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1 AIDS Res. Hum. Retroviruses 19 (2), 151-160 (2003) 3e-88 53
25PR
28RT
53
25PR
28RT
100 HIVDB
Hanna (2000) PATTERNS of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine J. Infect. Dis. 181 (3), 904-911 (2000) 1e-130  
14
14PR
14RT
0 ARV Rx and/or other data are N/A
Hanna (2002) DRUG-SELECTED resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection J. Infect. Dis. 188 (7), 986-991 (2003) 1e-126 176
88PR
88RT
176
88PR
88RT
100 HIVDB
Harrigan (2007) A 21-Base Pair Insertion/Duplication at Codon 69 of the HIV Type 1 Reverse Transcriptase in a Patient Undergoing Multiple Nucleoside Therapy AIDS Res. Hum. Retroviruses 23 (7), 895-899 (2007) 0  
10
10RT
0 Pending
Harris (2005) GENOMIC Characterization of a Novel HIV Type 1 B/G Intersubtype Recombinant Strain from an Injecting Drug User in Germany AIDS Res. Hum. Retroviruses 21 (7), 654-660 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Harris (2002) AMONG 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate AIDS Res. Hum. Retroviruses 18 (17), 1281-1290 (2002) 1e-166 45
45PR
44RT
45IN
45
45PR
45RT
45IN
100 HIVDB
Harris (2003) A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions AIDS Res. Hum. Retroviruses 19 (12), 1125-1133 (2003) 0 6
6PR
6RT
6IN
6
6PR
6RT
6IN
100 HIVDB
Hase (2010) The different trend in epidemiology of HIV-1 in a local cohort within Japan Unpublished 0  
94
62PR
69RT
0 Unpublished
Hasegawa (1989) GENOMIC divergence of HIV-2 from Ghana AIDS Res. Hum. Retroviruses 5 (6), 593-604 (1989) 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Hassaine (2000) CHARACTERIZATION of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals Virology 276 (1), 169-180 (2000) 0.02  
42
42IN
0 Gene fragment(s)
Hatano (2009) Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy J. Acquir. Immune Defic. Syndr. (2010) 1e-167 134
134IN
142
142IN
94 HIVDB
Hawkins (2009) Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first line antiretroviral therapy in Nigeria J. Acquir. Immune Defic. Syndr. 52, 2 (2010) 0 336
336PR
336RT
336
4PR
336RT
100 HIVDB
Held (2007) CROSS-CLADE inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers J. Virol. 81 (10), 5375-5384 (2007) 0  
1
1RT
0 Laboratory/experimental isolate
Henry (2005) FACTORS Associated with Time to CD4 Count < 350 cells/mm3 After Treatment Interruption Following Effective Antiretroviral Therapy (ART) +/- Interleukin-2 (IL-2): Results of a Pilot Study (ACTG A5102) Unpublished 0  
55
47PR
55RT
0 Pending
Heredia (1997) EVIDENCE of HIV-2 infection in Equatorial Guinea (Central Africa): Partial genetic analysis of a B subtype virus AIDS Res. Hum. Retroviruses 13, 437-439 (1997) 4.2 1
1RT
1
1RT
100 HIVDB
Heredia (2001) GENETIC analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS AIDS Res. Hum. Retroviruses 13 (10), 899-900 (1997) 2e-86 1
1RT
1
1RT
100 HIVDB
Hermankova (2001) HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy JAMA 286 (2), 196-207 (2001) 1e-126  
47
47PR
47RT
0 Evolution/quasispecies study
Herring (2001) NATURAL Variation in HIV-1 Integrase Unpublished 1e-165 81
81IN
81
81IN
100 HIVDB
Herring (2005) POTENTIAL drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A AIDS Res. Hum. Retroviruses 20 (9), 1010-1014 (2004) 1e-162 8
8IN
8
8IN
100 HIVDB
Heuverswyn (2007) GENETIC diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon Virology 368 (1), 155-171 (2007) 1e-100  
8
8IN
0 Pending
Hierholzer (2002) HIV type 1 strains from East and West Africa are intermixed in Sudan AIDS Res. Hum. Retroviruses 18 (15), 1163-1166 (2002) 1e-130 30
30PR
30RT
30
30PR
30RT
100 HIVDB
Hierholzer (2003) MOLECULAR Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina AIDS Res. Hum. Retroviruses 18 (18), 1339-1350 (2002) 1e-164 10
10PR
10RT
10IN
10
10PR
10RT
10IN
100 HIVDB
Hirano (2010) Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones Unpublished 0  
6
6RT
6IN
0 Laboratory/experimental isolate
Hirigoyen (2005) USE of Sequence Data Generated in the Bayer TruGene Genotyping Assay To Recognize and Characterize Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains J. Clin. Microbiol. 43 (10), 5263-5271 (2005) 1e-144  
29
6PR
29RT
0 ARV Rx and/or other data are N/A
Hirsch (1997) A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3 J. Virol. 71 (2), 1608-1620 (1997) 1e-100 1
1PR
1RT
1
1RT
1IN
100 HIVDB
Hirsch (1993) A distinct African lentivirus from Sykes' monkeys J. Virol. 67 (3), 1517-1528 (1993) 3e-91 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Hirsch (1993) DIRECT Submission Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Hirsch (1995) INDUCTION of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication J. Virol. 69 (2), 955-967 (1995) 1e-06 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Hirsch (1999) CHARACTERIZATION of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses J. Virol. 73 (2), 1036-1045 (1999) 0.017 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Hirsch (2000) HUMAN retrovirses, cancer and AIDS: approach to prevention and therapy Unpublished 4.2 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Ho (2009) Drug-Associated Changes in Amino Acid Residues in Gag p2, p7NC, and p6Gag/p6Pol in Human Immunodeficiency Virus Type 1 (HIV-1) Display a Dominant Effect on Replicative Fitness and Drug Response Unpublished 3e-50  
9
9PR
0 Case report(s) / study subset
Ho (2010) Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor AIDS 23 (13), 1631-1640 (2009) 1e-52  
402
402PR
0 Pending
Hoelscher (2001) HIGH proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania AIDS 15 (12), 1461-1470 (2001) 1e-166 9
9PR
9RT
9IN
9
9PR
9RT
9IN
100 HIVDB
Holguin Fernandez (2008) RAPID Increase of HIV-1 Non-B Subtypes and Recombinants Among Newly Diagnosed Native Spaniards Curr HIV Res. 2008 Jun;6(4):327-34. 0  
5
1PR
4RT
0 Pending
Holguin (1999) HUMAN immunodeficiency virus type 1 subtypes circulating in Portugal Unpublished 1e-126 29
29PR
31
31PR
93 HIVDB
Holguin (2000) HIV-1 subtype J recombinant viruses in Spain AIDS Res. Hum. Retroviruses 18 (7), 523-529 (2002) 1e-90 18
5PR
13RT
19
6PR
13RT
94 HIVDB
Holguin (2000) PROTEASE gene analysis of HIV type 1 non-B subtypes in Spain AIDS Res. Hum. Retroviruses 16 (14), 1395-1403 (2000) 2e-92 15
15PR
15
15PR
100 HIVDB
Holguin (2001) PREVALENCE of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5 J. Clin. Microbiol. 39 (5), 1850-1854 (2001) 1e-126 32
32PR
32
32PR
100 HIVDB
Holguin (2001) HIV-1 subtype J recombinant viruses in Spain AIDS Res. Hum. Retroviruses 18 (7), 523-529 (2002) 3e-69 1
1RT
1
1RT
100 HIVDB
Holguin (2002) HIGH prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid AIDS 16 (8), 1163-1170 (2002) 1e-102 43
43PR
44
44PR
97 HIVDB
Holguin (2002) INCREASING prevalence and heterogeneous nature of HIV-1 subtype G recombinants spreading in Spain Unpublished 1e-123 70
38PR
32RT
70
38PR
32RT
100 HIVDB
Holguin (2002) THE Canary Islands (Spain) as a key entrance of HIV-1 non-B subtypes in Southern Europe Unpublished 2e-98 18
1PR
17RT
18
1PR
17RT
100 HIVDB
Holguin (2003) HETEROGENEOUS nature of HIV-1 recombinants spreading in Spain J. Med. Virol. 75 (3), 374-380 (2005) 5e-83 5
3PR
2RT
5
3PR
2RT
100 HIVDB
Holguin (2003) DIFFERENCES in the Length of Gag Proteins among Different HIV Type 1 Subtypes AIDS Res. Hum. Retroviruses 21 (10), 886-893 (2005) 1e-50 46
46PR
46
46PR
100 HIVDB
Holguin (2004) IMPACT of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes J. Clin. Virol. 31 (3), 215-220 (2004) 3e-50 21
21PR
21
21PR
100 HIVDB
Holguin (2004) HIV-1 subtypes in Spain HIV Med. 2005 Sep;6(5):313-20. 8e-51  
14
14PR
0 Pending
Holguin (2004) DIFFERENCES in the Length of Gag Proteins among Different HIV Type 1 Subtypes AIDS Res. Hum. Retroviruses 21 (10), 886-893 (2005) 4e-53 56
56PR
56
56PR
100 HIVDB
Holguin (2006) INTRODUCTION of Non-B Subtypes among Spaniards Newly Diagnosed with HIV Type 1 in the Canary Islands AIDS Res. Hum. Retroviruses 23 (4), 498-502 (2007) 0 18
17PR
18RT
25
11PR
22RT
72 HIVDB
Holguin (2007) NEGATIVE line immunoassay in a HIV-1 subtype D- infected patient with positive serological tests for HIV Unpublished 1e-50  
1
1PR
0 Case report(s) / study subset
Holguin (2007) INCREASE of prevalence of HIV-1 non-B subtypes and recombinants among Spanish native population from 2000 to 2007 Curr HIV Res. 2008 Jun;6(4):327-34. 0  
208
148PR
191RT
0 Pending
Holguin (2008) GENETIC characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools J. Med. Virol. 80 (3), 383-391 (2008) 0 5
5PR
4RT
1IN
5
4RT
3IN
100 HIVDB
Holguin (2008) RAPID Increase of HIV-1 Non-B Subtypes and Recombinants Among Newly Diagnosed Native Spaniards Unpublished 0  
48
17PR
37RT
0 Pending
Holguin (2008) HIV-1 subtypes in newly diagnosed patients in Gran Canaria, Spain (2004-2006) Unpublished 0  
120
67PR
120RT
0 Pending
Holguin (2008) Increase of prevalence of HIV-1 non-B subtypes and recombinants among Spanish native population from 2000 to 2007 Unpublished 5e-49  
8
8PR
0 Pending
Holguin (2011) Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009 Pediatr. Infect. Dis. J. 30 (5), E82-E87 (2011) 5e-52  
51
51PR
0 Pending
Holler (1994) HIV1 integrase expressed in Escherichia coli from a synthetic gene Gene 136 (1-2), 323-328 (1993) 1e-165  
1
1IN
0 Laboratory/experimental isolate
Holzmayer (2005) NEAR-FULL-LENGTH genomic sequence of a human immunodeficiency type 1 subtype g strain from cameroon AIDS Res. Hum. Retroviruses 21 (5), 414-419 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Holzmayer (2009) Characterization of genetically diverse HIV type 1 from a London cohort: near full-length genomic analysis of a subtype H strain AIDS Res. Hum. Retroviruses 25 (7), 721-726 (2009) 0 15
1PR
1RT
15IN
15
1RT
15IN
100 HIVDB
Hong (2007) CHARACTERISTICS of a novel resistant HIV-1 strain against Tenofovir Unpublished 1e-144  
1
1RT
0 Laboratory/experimental isolate
Hoof (2010) Interdisciplinary analysis of HIV-specific CD8(+) T cell responses against variant epitopes reveals restricted TCR promiscuity J. Immunol. 184 (9), 5383-5391 (2010) 1e-152  
24
14PR
17RT
0 Pending
Hooker (1996) AN in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine J. Virol. 70 (11), 8010-8018 (1996) 2e-91  
2
2RT
0 HIVDB
Howard (1997) SEQUENCE analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria AIDS Res. Hum. Retroviruses 10 (12), 1755-1757 (1994) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Hu (2003) CHARACTERIZATION and Comparison of Recombinant Simian Immunodeficiency Virus from Drill (Mandrillus leucophaeus) and Mandrill (Mandrillus sphinx) Isolates J. Virol. 77 (8), 4867-4880 (2003) 1e-122 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Hu (2007) VIROLOGIC characterization of human immunodeficiency virus type 1 with a codon 70 deletion in reverse transcriptase Unpublished 0  
1
1RT
0 Case report(s) / study subset
Huang (2003) SEQUENCE characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel AIDS Res. Hum. Retroviruses 19 (4), 321-328 (2003) 1e-130 44
44PR
44RT
44
44PR
44RT
100 HIVDB
Huang (2009) Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC) AIDS Res. Hum. Retroviruses 25 (10), 1039-1043 (20 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Huang (2006) GENETIC characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian Province, China Chin. Med. J. 119 (19), 1622-1628 (2006) 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Huang (2006) GENETIC Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China AIDS Res. Hum. Retroviruses 23 (4), 569-574 (2007) 0 10
10PR
10RT
10IN
10
7PR
10RT
10IN
100 HIVDB
Huang (1998) COMPLETE sequence of type B HIV-1 Taiwan strain Unpublished 1e-162  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Hudelson (2010) Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration AIDS 24 (4), 557-561 (2010) 0  
60
13PR
60RT
0 Pending
Hue (2003) HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy AIDS 18 (5), 719-728 (2004) 1e-130  
138
138PR
138RT
0 ARV Rx and/or other data are N/A
Hue (2009) Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals J. Virol. 83 (6), 2645-2654 (2009) 0  
41
24PR
32RT
0 Evolution/quasispecies study
Hue (2011) HIV-1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination AIDS Res. Hum. Retroviruses (2011) In press 1e-177 32
32PR
32RT
159
1PR
159RT
20 HIVDB
Hue (2004) GENETIC analysis reveals the complex structure of HIV-1 transmission within defined risk groups Proc. Natl. Acad. Sci. U.S.A. 102 (12), 4425-4429 (2005) 1e-126  
223
223PR
223RT
0 ARV Rx and/or other data are N/A
Huet (1995) GENETIC organization of a chimpanzee lentivirus related to HIV-1 Nature 345 (6273), 356-359 (1990) 1e-157 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Huet (1989) A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot AIDS 3 (11), 707-715 (1989) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Hughes (2009) Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom PLoS Pathog. 5 (9), E1000590 (2009) 0  
301
43PR
266RT
0 Evolution/quasispecies study
Hunt (2002) CHARACTERISATION of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates Virus Genes 26 (1), 49-56 (2003) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Ibanez (2000) HUMAN immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies J. Gen. Virol. 81 (Pt 1), 85-95 (2000) 1e-121  
86
86PR
0 Evolution/quasispecies study
Ibe (2008) TREND of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006 AIDS Res. Hum. Retroviruses 24 (1), 7-14 (2008) 1e-139 363
363PR
363RT
363
354PR
56RT
100 HIVDB
Ibe (2008) ANALYSIS of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity AIDS Res. Hum. Retroviruses 24 (8), 1121-1125 (2008) 0 12
12PR
12RT
12IN
12
9PR
12RT
12IN
100 HIVDB
Ibe (2010) HIV-2 CRF01_AB: first circulating recombinant form of HIV-2 J. Acquir. Immune Defic. Syndr. 54 (3), 241-247 (2 0  
3
3RT
3IN
0 Pending
Ida (2000) HORIZONTAL Transmission of HIV-1 from Hemophiliac Son to Father Unpublished 1e-133  
34
34RT
0 Evolution/quasispecies study
Ignacio (2008) NOVEL Protease Insertion in HIV Type-1 AIDS Res. Hum. Retroviruses (2008) In press 1e-178  
1
1RT
0 Case report(s) / study subset
Imamichi (2001) HUMAN immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy J. Infect. Dis. 183 (1), 36-50 (2001) 1e-126  
644
644PR
0 Evolution/quasispecies study
Imamichi (2011) Rerunning the Tape of Evolution: An Empirical Example with HIV Unpublished 3e-52  
50
50PR
0 Evolution/quasispecies study
Iqbal (2010) Primary HIV-1 Drug Resistance and Polymorphic Patterns Among Injecting Drug Users (IDUs) in Chennai, Southern India J Int Assoc Physicians AIDS Care 8, 323-327 (2009) 4e-49 4
4PR
4
4PR
100 HIVDB
Isarangkura-na-ayuthaya (2010) Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients AIDS Res. Hum. Retroviruses (2010) In press 1e-165 78
78IN
78
78IN
100 HIVDB
Ishizaki (2009) Profile of HIV Type 1 Infection and Genotypic Resistance Mutations to Antiretroviral Drugs in Treatment-Naive HIV Type 1-Infected Individuals in Hai Phong, Viet Nam AIDS Res. Hum. Retroviruses 25 (2), 175-182 (2009) 1e-152 410
408PR
389RT
410
333PR
218RT
100 HIVDB
Iweriebor (2010) Molecular epidemiology of HIV in two highly endemic areas of north-eastern South Africa Unpublished 1e-168 53
13PR
40RT
59
15PR
44RT
89 HIVDB
Iweriebor (2010) Near full-length genomic analysis of an HIV type 1 subtype A1/C recombinant isolate from Limpopo province in South Africa Unpublished 0  
1
1RT
1IN
0 Unpublished
Iweriebor (2010) Genetic Characterization of HIV-1 Unique C/CRF11_cpx Recombinant Form from Limpopo Province, South Africa Unpublished 0  
2
1RT
1IN
0 Unpublished
Izopet (1998) EVOLUTION of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression Virology 302 (2), 393-404 (2002) 1e-129  
278
18PR
260RT
0 Evolution/quasispecies study
Izopet (2000) SHIFT in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen AIDS 14 (15), 2247-2255 (2000) 1e-133  
152
76PR
76RT
0 Evolution/quasispecies study
Izopet (2002) EVOLUTION of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype J. Infect. Dis. 185 (10), 1506-1510 (2002) 1e-133  
306
149PR
157RT
0 Evolution/quasispecies study
Jackson (2002) IDENTIFICATION of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission AIDS 14 (11), F111-F115 (2000) 3e-22 15
15RT
15
15RT
100 HIVDB
Jacobs (2007) COMPLETE Genome Sequencing of a Non-syncytium-Inducing HIV Type 1 Subtype D Strain from Cape Town, South Africa AIDS Res. Hum. Retroviruses 23 (12), 1575-1578 (2007) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Jacobs (2008) MOLECULAR Analysis of HIV Type 1 vif Sequences from Cape Town, South Africa AIDS Res. Hum. Retroviruses 24 (7), 991-994 (2008) 0.027  
1
1IN
0 Gene fragment(s)
Jacobs (2008) PHYLOGENETIC Diversity and Low Level Antiretroviral Resistance Mutations in HIV Type 1 Treatment-Naive Patients from Cape Town, South Africa AIDS Res. Hum. Retroviruses 24 (7), 1009-1012 (2008) 1e-149 103
94PR
88RT
103
45PR
79RT
100 HIVDB
Jacobson (2006) EVIDENCE That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC-HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068 J. Infect. Dis. 194 (5), 623-632 (2006) 6e-51  
2
2PR
0 Case report(s) / study subset
Jain (2010) Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes J. Infect. Dis. 203 (8), 1174-1181 (2011) 8e-52  
78
78PR
0 Pending
Jallow (2006) VIROLOGICAL and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia AIDS 20 (10), 1455-1458 (2006) 1e-160  
28
28RT
0 Pending
Jallow (2007) DEVELOPMENT and Evaluation of an Oligonucleotide Ligation Assay for Detection of Drug Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 2 pol Gene J. Clin. Microbiol. 45 (5), 1565-1571 (2007) 1e-160  
26
26RT
0 Pending
Jallow (2009) Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau Clin. Infect. Dis. 48 (12), 1790-1793 (2009) 1e-157  
1
1RT
0 Pending
Jallow (2009) Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants J. Clin. Microbiol. 47 (7), 2200-2208 (2009) 1e-159  
11
11RT
0 Pending
Janin (2009) Low Prevalence of Drug Resistance Transmitted Virus in HIV Type 1-Infected ARV-Naive Patients in Cambodia AIDS Res. Hum. Retroviruses 25 (5), 543-545 (2009) 8e-51 48
48PR
48
48PR
100 HIVDB
Janini (1996) HORIZONTAL and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C J. Infect. Dis. 177 (1), 227-231 (1998) 1e-130 39
39PR
42
42PR
92 HIVDB
Janini (2001) HUMAN immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells J. Virol. 75 (17), 7973-7986 (2001) 1e-133  
350
350PR
0 ARV Rx and/or other data are N/A
Janssens (1995) DIRECT Submission Unpublished 3e-42  
1
1IN
0 Gene fragment(s)
Janssens (1995) FURTHER evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon AIDS 8 (7), 1012-1013 (1994) 8e-41  
2
2IN
0 Gene fragment(s)
Janssens (2000) HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants AIDS 14 (11), 1533-1543 (2000) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Janssens (2000) NEAR full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants AIDS Res. Hum. Retroviruses 16 (12), 1183-1189 (2000) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Jenwitheesuk (2002) PREVALENCE of genotypic HIV-1 drug resistance in Thailand, 2002 Ann Clin Microbiol Antimicrob 2 (1), 4 (2003) 1e-126  
170
82PR
88RT
0 ARV Rx and/or other data are N/A
Jin (1994) MOSAIC genome structure of simian immunodeficiency virus from west African green monkeys EMBO J. 13 (12), 2935-2947 (1994) 1e-124 1
1PR
1RT
1IN
2
1PR
2RT
1IN
50 HIVDB
Jinnopat (2009) Impact of Amino Acid Variations in Gag and Protease of Human Immunodeficiency Virus Type 1 CRF01_AE strains on Drug Susceptibility of Virus to Protease Inhibitors J. Acquir. Immune Defic. Syndr. (2009) In press 3e-50 5
5PR
5
5PR
100 Case report(s) / study subset
Johnson (1990) SIMIAN immunodeficiency viruses from African green monkeys display unusual genetic diversity J. Virol. 64 (3), 1086-1092 (1990) 1e-111 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Johnson (2001) VERTICAL transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant J. Infect. Dis. 183 (11), 1688-1693 (2001) 1e-112  
6
6PR
6RT
0 Evolution/quasispecies study
Johnson (2007) DETECTION of HIV Drug Resistance at Regimen Failure during Sequential 3-Drug versus Initial 4-Drug HAART Strategies in AIDS Clinical Trials Group Protocol 384 J. Acquir. Immune Defic. Syndr. (2007) In press 0 731
731PR
731RT
731
711PR
151RT
100 HIVDB
Johnson (2007) Detection of HIV Drug Resistance at Regimen Failure during Sequential 3-Drug versus Initial 4-Drug HAART Strategies in AIDS Clinical Trials Group Protocol 384 J. Acquir. Immune Defic. Syndr. (2007) In press 3e-47 3
3PR
3RT
3
3PR
100 HIVDB
Johnston (2004) PANEL of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations AIDS 19 (7), 731-733 (2005) 1e-158 2
2RT
2
2RT
100 HIVDB
Jonassen (1997) SEQUENCE analysis of HIV-1 group O from Norwegian patients infected in the 1960s Virology 231 (1), 43-47 (1997) 1e-102 3
1PR
1RT
1IN
4
2PR
1RT
2IN
75 HIVDB
Jonassen (2000) INTERSUBTYPE recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases AIDS Res. Hum. Retroviruses 16 (1), 49-58 (2000) 1e-162 1
1PR
1RT
1IN
7
5PR
2RT
3IN
14 HIVDB
Jones (2005) GENETIC Linkage of Nevirapine Resistance Mutations in HIV Type 1 Seven Days after Single-Dose Nevirapine AIDS Res. Hum. Retroviruses 21 (4), 319-324 (2005) 0 2
2PR
2RT
2
1PR
2RT
100 HIVDB
Jones (2009) In-depth analysis of the origins of HIV type 1 subtype C in South America AIDS Res. Hum. Retroviruses 25 (10), 951-959 (2009 0 4
4PR
4RT
4
4RT
100 HIVDB
Jorgensen (2000) GENOTYPIC and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine Antivir. Ther. (Lond.) 5 (3), 187-194 (2000) 1e-127 73
37PR
36RT
76
39PR
37RT
96 HIVDB
Jorgensen (2002) GENOTYPIC and phenotypic resistance in cultured HIV reflect the genotype and phenotype of viral RNA in plasma Unpublished 1e-108  
34
17PR
17RT
0 Case report(s) / study subset
Jorgensen (2002) PREVALENCE of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark Unpublished 1e-128 97
96PR
97RT
97
96PR
97RT
100 HIVDB
Jost (2002) A patient with HIV-1 superinfection N. Engl. J. Med. 347 (10), 731-736 (2002) 1e-107  
4
2PR
2RT
0 Case report(s) / study subset
Jullaksorn (2010) Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients Southeast Asian J. Trop. Med. Public Health 41 (2) 0 271
118PR
153RT
271
118PR
153RT
100 HIVDB
K'Aluoch (2004) HIGH Frequency of Recombinant A and D HIV-1 subtypes in a Population from Uganda (in) 12TH CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFEC 0 29
29PR
29RT
29
29PR
29RT
100 HIVDB
K'Aluoch (2005) CHARACTERIZATION of HIV-1 Subtypes and Recombinants in a Uganda Cohort by use of the gag, nef and pol Genes Unpublished 0 37
34PR
37RT
37
34PR
37RT
100 HIVDB
Kalmar (2009) Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after 6 months of therapeutic interruption Unpublished 1e-172  
74
56PR
35RT
0 Unpublished
Kandathil (2007) A Comparison of Interpretation by Three Different HIV Type 1 Genotypic Drug Resistance Algorithms Using Sequences from Non-Clade B HIV Type 1 Strains AIDS Res. Hum. Retroviruses 25 (3), 315-318 (2009) 1e-169 115
112PR
115RT
124
17PR
120RT
92 HIVDB
Kandathil (2008) Does India need a transmitted drug resistance surveillance network for HIV? Unpublished 1e-166 2
2PR
2RT
2
2RT
100 HIVDB
Kantor (2002) EVOLUTION of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy Antimicrob. Agents Chemother. 46 (4), 1086-1092 (2002) 1e-126 76
75PR
1RT
114
114PR
66 HIVDB
Kantor (2003) HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy AIDS Res. Hum. Retroviruses 18 (18), 1407-1413 (2002) 1e-87 20
20PR
20RT
21
21PR
21RT
95 HIVDB
Kantor (2004) EVOLUTION of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy AIDS 18 (11), 1503-1511 (2004) 1e-180 204
96PR
108RT
427
209PR
218RT
47 HIVDB
Kantor (2005) IMPACT of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration PLoS Med 2 (4), E112 (2005) 0 884
292PR
592RT
1018
394PR
624RT
86 HIVDB
Kao (2011) Surveillance of HIV Type 1 Recent Infection and Molecular Epidemiology Among Different Risk Behaviors Between 2007 and 2009 After the HIV Type 1 CRF07_BC Outbreak in Taiwan AIDS Res. Hum. Retroviruses 27 (7), 745-749 (2011) 0 381
381PR
378RT
381
316PR
378RT
100 HIVDB
Karchava (2006) PREVALENCE of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State J. Acquir. Immune Defic. Syndr. 42 (5), 614-619 (2006) 0  
14
9PR
13RT
0 Case report(s) / study subset
Karlsson (2001) RECENT origin of HIV-1 variants in resting CD4+ T-lymphocytes in untreated and suboptimally treated subjects Unpublished 1e-126  
134
134PR
133RT
0 Evolution/quasispecies study
Karlsson (2007) SEQUENTIAL Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape PLoS ONE 2, E225 (2007) 1e-141  
83
81PR
83RT
0 Evolution/quasispecies study
Karlsson (2007) ANTIRETROVIRAL drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from gag to pol J. Virol. 81 (20), 11543-11548 (2007) 1e-142  
10
4PR
8RT
0 Case report(s) / study subset
Kasang (2010) High prevalence of transmitted drug resistance mutations in therapy naive HIV-1 infected patients in Mwanza, Lake Victoria zone, Tanzania Unpublished 0 89
89PR
89RT
89
15PR
89RT
100 HIVDB
Kassaye (2008) Envelope co-receptor tropism, drug resistance, and viral evolution among subtype C HIV-1 infected individuals receiving non-suppressive antiretroviral therapy Unpublished 1e-165 16
16PR
16RT
16
11PR
9RT
100 HIVDB
Kassu (2006) MOLECULAR epidemiology of HIV type 1 in treatment-naive patients in north Ethiopia AIDS Res. Hum. Retroviruses 23 (4), 564-568 (2007) 1e-153 92
92PR
92RT
92
71PR
92RT
100 HIVDB
Kato (2004) COMPARISON of genotypic assay and peripheral blood mononuclear cell-based phenotypic assay in HIV-1 antiretroviral drug resistance Unpublished 1e-159  
112
56PR
56RT
0 ARV Rx and/or other data are N/A
Katzenstein (2007) SEVENTEEN-YEAR-OLD mother-to-child HIV type 1 transmission identified by phylogeny and signature patterns AIDS Res. Hum. Retroviruses 24 (8), 1117-1120 (2008) 0  
3
3RT
0 Case report(s) / study subset
Kaufmann (2001) IMPACT of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs AIDS Res. Hum. Retroviruses 17 (6), 487-497 (2001) 1e-130  
42
42PR
42RT
0 ARV Rx and/or other data are N/A
Kawashima (2009) Adaptation of HIV-1 to human leukocyte antigen class I Nature 458 (7238), 641-645 (2009) 4e-26  
290
290IN
0 Gene fragment(s)
Kaye (2001) OBSERVATIONS of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial) Antivir. Ther. (Lond.) (2001) In press 9e-94 58
58RT
58
58RT
100 HIVDB
Kazennova (2011) Direct Submission Submitted (10-AUG-2010) T-Lymphotropic Viruses Lab 0  
82
31PR
82RT